BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14:119-36. [PMID: 26043321 DOI: 10.1002/wps.20204] [Cited by in Crossref: 366] [Cited by in F6Publishing: 330] [Article Influence: 52.3] [Reference Citation Analysis]
Number Citing Articles
1 Puntervold OE, Kruckow L, Banner J. Undiagnosed disease in decedents with and without schizophrenia: an autopsy-based case-control study. Nord J Psychiatry 2021;:1-7. [PMID: 33823753 DOI: 10.1080/08039488.2021.1905877] [Reference Citation Analysis]
2 Lin M, Li H, Zhao Y, Cai E, Zhu H, Gao Y, Liu S, Yang H, Zhang L, Tang G, Wang R. Ergosteryl 2-naphthoate, An Ergosterol Derivative, Exhibits Antidepressant Effects Mediated by the Modification of GABAergic and Glutamatergic Systems. Molecules 2017;22:E565. [PMID: 28362353 DOI: 10.3390/molecules22040565] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Rahman MR, Islam T, Nicoletti F, Petralia MC, Ciurleo R, Fisicaro F, Pennisi M, Bramanti A, Demirtas TY, Gov E, Islam MR, Mussa BM, Moni MA, Fagone P. Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis. Genes (Basel) 2021;12:237. [PMID: 33562405 DOI: 10.3390/genes12020237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Castillo-Sánchez M, Escurriola MF, Sanmartín MIF, Solntseva I, Baquero DB, Arno AG. Cardiovascular disease and mortality in people with schizophrenia or antipsychotic treatment: A cohort study in primary care. Psychiatry Res 2021;306:114233. [PMID: 34678582 DOI: 10.1016/j.psychres.2021.114233] [Reference Citation Analysis]
5 Shafie S, Lee SP, Ong SBC, Wang P, Seow E, Ong HL, Chong SA, Subramaniam M. Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore. Singapore Med J 2018;59:465-71. [PMID: 29430576 DOI: 10.11622/smedj.2018020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
6 Vancampfort D, Probst M, Rosenbaum S, Ward PB, Van Damme T, Mugisha J. Sedentary Behavior and Quality of Life in People with Psychotic Disorders from a Low Income Country: A Study from Uganda. Community Ment Health J 2019;55:714-20. [PMID: 30519804 DOI: 10.1007/s10597-018-0353-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Pérez-Piñar M, Mathur R, Foguet Q, Ayis S, Robson J, Ayerbe L. Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders. Eur Psychiatry 2016;35:8-15. [PMID: 27061372 DOI: 10.1016/j.eurpsy.2016.02.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
8 Fornaro M, De Berardis D, Koshy AS, Perna G, Valchera A, Vancampfort D, Stubbs B. Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review. Neuropsychiatr Dis Treat 2016;12:719-35. [PMID: 27099503 DOI: 10.2147/NDT.S100846] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
9 Patel P, Frederick T, Kidd SA. Physical health, community participation and schizophrenia. J Health Psychol 2018;23:79-83. [PMID: 27624616 DOI: 10.1177/1359105316666654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Abrahamian H, Kautzky-Willer A, Rießland-Seifert A, Fasching P, Ebenbichler C, Kautzky A, Hofmann P, Toplak H. [Mental disorders and diabetes mellitus (Update 2019)]. Wien Klin Wochenschr 2019;131:186-95. [PMID: 30980168 DOI: 10.1007/s00508-019-1458-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Arterburn D, Wood GC, Theis MK, Westbrook EO, Anau J, Rukstalis M, Boscarino JA, Daar Z, Gerhard GS. Antipsychotic medications and extreme weight gain in two health systems. Obes Res Clin Pract 2016;10:408-23. [PMID: 26361961 DOI: 10.1016/j.orcp.2015.08.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
12 Khan MM. Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia. CNS Drugs 2016;30:589-601. [DOI: 10.1007/s40263-016-0343-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
13 Jin J, Zhang K, Dou F, Hao C, Zhang Y, Cao X, Gao L, Xiong J, Liu X, Liu B, Zhang G, Chen Y. Isoquinolinone derivatives as potent CNS multi-receptor D2/5-HT1A/5-HT2A/5-HT6/5-HT7 agents: Synthesis and pharmacological evaluation. European Journal of Medicinal Chemistry 2020;207:112709. [DOI: 10.1016/j.ejmech.2020.112709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Delacrétaz A, Vandenberghe F, Gholam-Rezaee M, Saigi Morgui N, Glatard A, Thonney J, Solida-Tozzi A, Kolly S, Gallo SF, Baumann P, Berney S, Zulauff SV, Aubry JM, Hasler R, Ebbing K, von Gunten A, Conus P, Eap CB. Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia. J Clin Lipidol 2018;12:219-29. [PMID: 29128242 DOI: 10.1016/j.jacl.2017.10.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
15 Yuan M, Xiao ZL, Zhou HY, Rao W, Huang G, Nie HB, Cao WF, Xu RS. Bipolar disorder and the risk for stroke incidence and mortality: a meta-analysis. Neurol Sci 2021. [PMID: 34052937 DOI: 10.1007/s10072-021-05348-2] [Reference Citation Analysis]
16 Capuzzi E, Bartoli F, Crocamo C, Malerba MR, Clerici M, Carrà G. Recent suicide attempts and serum lipid profile in subjects with mental disorders: A cross-sectional study. Psychiatry Research 2018;270:611-5. [DOI: 10.1016/j.psychres.2018.10.050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
17 Jaeschke RR, Sowa-kućma M, Pańczyszyn-trzewik P, Misztak P, Styczeń K, Datka W. Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile. Pharmacological Reports 2016;68:748-55. [DOI: 10.1016/j.pharep.2016.04.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
18 Vancampfort D, Watkins A, Ward PB, Probst M, De Hert M, Van Damme T, Mugisha J. Barriers, attitudes, confidence, and knowledge of nurses regarding metabolic health screening and intervention in people with mental illness: a pilot study from Uganda. Afr Health Sci 2019;19:2546-54. [PMID: 32127827 DOI: 10.4314/ahs.v19i3.30] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Whicher CA, Price HC, Holt RIG. Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation. Eur J Endocrinol 2018;178:R245-58. [PMID: 29559497 DOI: 10.1530/EJE-18-0022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
20 Docherty M, Stubbs B, Gaughran F. Strategies to deal with comorbid physical illness in psychosis. Epidemiol Psychiatr Sci 2016;25:197-204. [PMID: 26888363 DOI: 10.1017/S2045796016000056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Givens AD, Blank Wilson A, Van Deinse TB, Murray-Lichtman A, Cuddeback GS. Physical Health Problems Among People With Severe Mental Illnesses: Race, Gender, and Implications for Practice. J Am Psychiatr Nurses Assoc 2021;27:283-91. [PMID: 34053320 DOI: 10.1177/10783903211014943] [Reference Citation Analysis]
22 Bressington D, Mui J, Tse ML, Gray R, Cheung EF, Chien WT. Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study. BMC Psychiatry 2016;16:411. [PMID: 27863522 DOI: 10.1186/s12888-016-1121-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
23 Teshome T, Kassa DH, Hirigo AT. Prevalence and Associated Factors of Metabolic Syndrome Among Patients with Severe Mental Illness at Hawassa, Southern-Ethiopia. Diabetes Metab Syndr Obes 2020;13:569-79. [PMID: 32161483 DOI: 10.2147/DMSO.S235379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Murray G. What Would Digital Early Intervention for Bipolar Disorder Look Like? Theoretical and Translational Considerations for Future Therapies. Front Psychiatry 2019;10:599. [PMID: 31507467 DOI: 10.3389/fpsyt.2019.00599] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
25 Fusar-Poli L, Amerio A, Cimpoesu P, Natale A, Salvi V, Zappa G, Serafini G, Amore M, Aguglia E, Aguglia A. Lipid and Glycemic Profiles in Patients with Bipolar Disorder: Cholesterol Levels Are Reduced in Mania. Medicina (Kaunas) 2020;57:28. [PMID: 33396922 DOI: 10.3390/medicina57010028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Phan SV, Lugin Y, Morgan K. Rates of new antipsychotic prescriptions and continuation at discharge from a medical unit in a community teaching hospital serving rural counties. Ment Health Clin 2019;9:88-92. [PMID: 30842916 DOI: 10.9740/mhc.2019.03.088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Romano E, Ma R, Perera G, Stewart R, Tsamakis K, Solmi M, Vancampfort D, Firth J, Stubbs B, Mueller C. Risk of hospitalised falls and hip fractures in working age adults receiving mental health care. Gen Hosp Psychiatry 2021;72:81-7. [PMID: 34332346 DOI: 10.1016/j.genhosppsych.2021.07.006] [Reference Citation Analysis]
28 Bishop-freeman SC, Hensel EM, Feaster MS, Winecker RE. Degradation of Bupropion: Implications for Interpretation of Postmortem Case Data. Journal of Analytical Toxicology 2018;42:525-36. [DOI: 10.1093/jat/bky058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Ayerbe L, Forgnone I, Addo J, Siguero A, Gelati S, Ayis S. Hypertension risk and clinical care in patients with bipolar disorder or schizophrenia; a systematic review and meta-analysis. J Affect Disord 2018;225:665-70. [PMID: 28915505 DOI: 10.1016/j.jad.2017.09.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
30 Masuda T, Misawa F, Takase M, Kane JM, Correll CU. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies. JAMA Psychiatry 2019;76:1052-62. [PMID: 31365048 DOI: 10.1001/jamapsychiatry.2019.1702] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 29.0] [Reference Citation Analysis]
31 Højlund M, Lund LC, Andersen K, Correll CU, Hallas J. Association of Low-Dose Quetiapine and Diabetes. JAMA Netw Open 2021;4:e213209. [PMID: 33961038 DOI: 10.1001/jamanetworkopen.2021.3209] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 McGrath JJ. No mental health without physical health - a call to arms. Epidemiol Psychiatr Sci 2016;25:195-6. [PMID: 26961496 DOI: 10.1017/S2045796015001055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Vancampfort D, Sienaert P, Wyckaert S, Probst M, De Herdt A, De Hert M, Stubbs B, Buys R. Cardiorespiratory fitness in outpatients with bipolar disorder versus matched controls: An exploratory study. Journal of Affective Disorders 2016;199:1-5. [DOI: 10.1016/j.jad.2016.03.057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
34 Alvarez-Mon MA, Donat-Vargas C, Santoma-Vilaclara J, de Anta L, Goena J, Sanchez-Bayona R, Mora F, Ortega MA, Lahera G, Rodriguez-Jimenez R, Quintero J, Álvarez-Mon M. Assessment of Antipsychotic Medications on Social Media: Machine Learning Study. Front Psychiatry 2021;12:737684. [PMID: 34867531 DOI: 10.3389/fpsyt.2021.737684] [Reference Citation Analysis]
35 Gallagher P, Boland C, McClenaghan A, Fanning F, Lawlor E, Clarke M. Improved self-esteem and activity levels following a 12-week community activity and healthy lifestyle programme in those with serious mental illness: A feasibility study. Early Interv Psychiatry 2021;15:367-73. [PMID: 32337860 DOI: 10.1111/eip.12965] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Bian X, Liu X, Liu J, Zhao Y, Li H, Cai E, Li P, Gao Y. Study on antidepressant activity of chiisanoside in mice. International Immunopharmacology 2018;57:33-42. [DOI: 10.1016/j.intimp.2018.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
37 Egher C. Bipolar patients and creative online practices: Sharing experiences of controversial treatments. Health (London) 2019;23:458-77. [PMID: 30919655 DOI: 10.1177/1363459319838315] [Reference Citation Analysis]
38 Adams DM, Reay WR, Geaghan MP, Cairns MJ. Investigation of glycaemic traits in psychiatric disorders using Mendelian randomisation revealed a causal relationship with anorexia nervosa. Neuropsychopharmacology 2021;46:1093-102. [PMID: 32920595 DOI: 10.1038/s41386-020-00847-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects. Curr Neuropharmacol 2018;16:1210-23. [PMID: 28676017 DOI: 10.2174/1570159X15666170630163616] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 8.3] [Reference Citation Analysis]
40 Mazereel V, Detraux J, Vancampfort D, van Winkel R, De Hert M. Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness. Front Endocrinol (Lausanne) 2020;11:573479. [PMID: 33162935 DOI: 10.3389/fendo.2020.573479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Gylvin SH, Jørgensen CC, Fink-Jensen A, Kehlet H. Psychiatric disease as a risk factor in fast-track hip and knee replacement. Acta Orthop 2016;87:439-43. [PMID: 26900724 DOI: 10.3109/17453674.2016.1151292] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
42 Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F, Vieta E, Seeman MV. Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review. Ther Clin Risk Manag. 2017;13:757-777. [PMID: 28721057 DOI: 10.2147/tcrm.s117321] [Cited by in Crossref: 153] [Cited by in F6Publishing: 51] [Article Influence: 30.6] [Reference Citation Analysis]
43 Javelot H, Llorca PM, Drapier D, Fakra E, Hingray C, Meyer G, Dizet S, Egron A, Straczek C, Roser M, Masson M, Gaillard R, Fossati P, Haffen E. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic]. Encephale 2020;46:S14-34. [PMID: 32376004 DOI: 10.1016/j.encep.2020.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Atolagbe A, Nkemjika S, Popoola O, Oladeji O, Kogan I, Saeed H, Olupona T. Risperidone-Induced Neutropenia in a Schizophrenic Patient: A Case Report and Literature Review. Case Rep Psychiatry 2021;2021:3980872. [PMID: 34447597 DOI: 10.1155/2021/3980872] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zhang B, Wang PP, Hu KL, Li LN, Yu X, Lu Y, Chang HS. Antidepressant-Like Effect and Mechanism of Action of Honokiol on the Mouse Lipopolysaccharide (LPS) Depression Model. Molecules 2019;24:E2035. [PMID: 31141940 DOI: 10.3390/molecules24112035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
46 Stubbs B, Williams J, Shannon J, Gaughran F, Craig T. Peer support interventions seeking to improve physical health and lifestyle behaviours among people with serious mental illness: A systematic review. International Journal of Mental Health Nursing 2016;25:484-95. [DOI: 10.1111/inm.12256] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
47 Al-Rawi S, Zolezzi M, Eltorki Y. Evaluation of cardiovascular risk in adult psychiatric outpatients in Qatar using two risk assessment tools. Qatar Med J 2021;2021:27. [PMID: 34604012 DOI: 10.5339/qmj.2021.27] [Reference Citation Analysis]
48 Vancampfort D, De Hert M, Myin-Germeys I, van Winkel R, Firth J, Van Damme T, Probst M. Lower cardiorespiratory fitness is associated with more time spent sedentary in first episode psychosis: A pilot study. Psychiatry Res 2017;253:13-7. [PMID: 28319786 DOI: 10.1016/j.psychres.2017.03.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
49 Ayerbe L, Forgnone I, Foguet-Boreu Q, González E, Addo J, Ayis S. Disparities in the management of cardiovascular risk factors in patients with psychiatric disorders: a systematic review and meta-analysis. Psychol Med 2018;48:2693-701. [PMID: 29490716 DOI: 10.1017/S0033291718000302] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
50 Zwicker A, MacKenzie LE, Drobinin V, Howes Vallis E, Patterson VC, Stephens M, Cumby J, Propper L, Abidi S, Bagnell A, Schultze-Lutter F, Pavlova B, Alda M, Uher R. Basic symptoms in offspring of parents with mood and psychotic disorders. BJPsych Open 2019;5:e54. [PMID: 31530297 DOI: 10.1192/bjo.2019.40] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
51 Chung KH, Chen PH, Kuo CJ, Tsai SY, Huang SH, Wu WC. Risk factors for early circulatory mortality in patients with schizophrenia. Psychiatry Res 2018;267:7-11. [PMID: 29879603 DOI: 10.1016/j.psychres.2018.05.044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
52 Pikalov A, Tsai J, Mao Y, Silva R, Cucchiaro J, Loebel A. Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment. Int J Bipolar Disord 2017;5:9. [PMID: 28168632 DOI: 10.1186/s40345-017-0075-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
53 Khan MM. Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders. Int J Endocrinol 2018;2018:9516592. [PMID: 30402099 DOI: 10.1155/2018/9516592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
54 Thomson S, Doan T, Liu D, Schubert KO, Toh J, Boyd MA, Galletly C. Supporting the vulnerable: developing a strategic community mental health response to the COVID-19 pandemic. Australas Psychiatry 2020;28:492-9. [PMID: 32729320 DOI: 10.1177/1039856220944701] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
55 Stubbs B, Vancampfort D, Veronese N, Kahl KG, Mitchell AJ, Lin P, Tseng P, Mugisha J, Solmi M, Carvalho AF, Koyanagi A. Depression and physical health multimorbidity: primary data and country-wide meta-analysis of population data from 190 593 people across 43 low- and middle-income countries. Psychol Med 2017;47:2107-17. [DOI: 10.1017/s0033291717000551] [Cited by in Crossref: 52] [Cited by in F6Publishing: 18] [Article Influence: 10.4] [Reference Citation Analysis]
56 Sheikh MA. Leisure time physical activity and incident use of prescription tranquilizers: A longitudinal population-based study. Journal of Affective Disorders 2018;238:327-35. [DOI: 10.1016/j.jad.2018.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Iversen TSJ, Steen NE, Dieset I, Hope S, Mørch R, Gardsjord ES, Jørgensen KN, Melle I, Andreassen OA, Molden E, Jönsson EG. Side effect burden of antipsychotic drugs in real life – Impact of gender and polypharmacy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;82:263-71. [DOI: 10.1016/j.pnpbp.2017.11.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
58 Heiberg IH, Jacobsen BK, Nesvåg R, Bramness JG, Reichborn-Kjennerud T, Næss Ø, Ystrom E, Hultman CM, Høye A. Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder. PLoS One 2018;13:e0202028. [PMID: 30138449 DOI: 10.1371/journal.pone.0202028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
59 van der Lee APM, de Haan L, Beekman ATF. Rising co-payments coincide with unwanted effects on continuity of healthcare for patients with schizophrenia in the Netherlands. PLoS One 2019;14:e0222046. [PMID: 31513629 DOI: 10.1371/journal.pone.0222046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
60 Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol 2021;18:136-45. [PMID: 33128044 DOI: 10.1038/s41569-020-00463-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
61 Gylvin SH, Fink-Jensen A, Kehlet H, Jørgensen CC, Laursen MB, Gromov K, Schroder HM, Høvsgaard SJ, Wede HR, Kyle PR, Bech P. Prospective psychometric characterization of hip and knee arthroplasty patients. Nord J Psychiatry 2018;72:39-44. [PMID: 29022751 DOI: 10.1080/08039488.2017.1381149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Chen PH, Kao YW, Shia BC, Lin HC, Kang JH. Adverse stroke outcomes among patients with bipolar disorder. PLoS One 2019;14:e0213072. [PMID: 30830937 DOI: 10.1371/journal.pone.0213072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Hawkins M, Leung SE, Lee A, Wnuk S, Cassin S, Hawa R, Sockalingam S. Psychiatric Medication Use and Weight Outcomes One Year After Bariatric Surgery. Psychosomatics 2020;61:56-63. [PMID: 31806241 DOI: 10.1016/j.psym.2019.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
64 Vermeulen J, van Rooijen G, Doedens P, Numminen E, van Tricht M, de Haan L. Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis. Psychol Med 2017;47:2217-28. [PMID: 28397632 DOI: 10.1017/S0033291717000873] [Cited by in Crossref: 41] [Cited by in F6Publishing: 16] [Article Influence: 8.2] [Reference Citation Analysis]
65 Correll CU, Vanover KE, Davis RE, Chen R, Satlin A, Mates S. Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia. Schizophr Res. 2021;228:198-205. [PMID: 33453691 DOI: 10.1016/j.schres.2020.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Nestsiarovich A, Kerner B, Mazurie AJ, Cannon DC, Hurwitz NG, Zhu Y, Nelson SJ, Oprea TI, Unruh ML, Crisanti AS, Tohen M, Perkins DJ, Lambert CG. Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy. J Affect Disord 2019;252:201-11. [PMID: 30986735 DOI: 10.1016/j.jad.2019.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
67 Filipcic I, Simunovic Filipcic I, Ivezic E, Matic K, Tunjic Vukadinovic N, Vuk Pisk S, Bodor D, Bajic Z, Jakovljevic M, Sartorius N. Chronic physical illnesses in patients with schizophrenia spectrum disorders are independently associated with higher rates of psychiatric rehospitalization; a cross-sectional study in Croatia. Eur psychiatr 2017;43:73-80. [DOI: 10.1016/j.eurpsy.2017.02.484] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
68 Greenwood J, Acharya RB, Marcellus V, Rey JA. Lumateperone: A Novel Antipsychotic for Schizophrenia. Ann Pharmacother. 2021;55:98-104. [PMID: 32590907 DOI: 10.1177/1060028020936597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
69 Orsolini L, De Berardis D, Volpe U. Up-to-date expert opinion on the safety of recently developed antipsychotics. Expert Opin Drug Saf 2020;19:981-98. [PMID: 32657173 DOI: 10.1080/14740338.2020.1795126] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
70 Rozing MP, Jønsson A, Køster-Rasmussen R, Due TD, Brodersen J, Bissenbakker KH, Siersma V, Mercer SW, Guassora AD, Kjellberg J, Kjellberg PK, Nielsen MH, Christensen I, Bardram JE, Martiny F, Møller A, Reventlow S; SOFIA Study Group. The SOFIA pilot trial: a cluster-randomized trial of coordinated, co-produced care to reduce mortality and improve quality of life in people with severe mental illness in the general practice setting. Pilot Feasibility Stud 2021;7:168. [PMID: 34479646 DOI: 10.1186/s40814-021-00906-z] [Reference Citation Analysis]
71 Burghardt KJ, Seyoum B, Dass SE, Sanders E, Mallisho A, Yi Z. Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder. Pharmacotherapy 2018;38:428-35. [PMID: 29484683 DOI: 10.1002/phar.2097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
72 Hackinger S, Prins B, Mamakou V, Zengini E, Marouli E, Brčić L, Serafetinidis I, Lamnissou K, Kontaxakis V, Dedoussis G, Gonidakis F, Thanopoulou A, Tentolouris N, Tsezou A, Zeggini E. Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia. Transl Psychiatry 2018;8:252. [PMID: 30470734 DOI: 10.1038/s41398-018-0304-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
73 Aschbrenner KA, Naslund JA, Reed JD, Fetter JC. Renewed call for lifestyle interventions to address obesity among individuals with serious mental illness in the COVID-19 era and beyond. Transl Behav Med 2021;11:1359-64. [PMID: 34160055 DOI: 10.1093/tbm/ibab076] [Reference Citation Analysis]
74 Wang HY, Huang CL, Feng IJ, Tsuang HC. Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case-control study. BMJ Open 2018;8:e019868. [PMID: 29794090 DOI: 10.1136/bmjopen-2017-019868] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
75 Brinkmann B, Payne CF, Kohler I, Harling G, Davies J, Witham M, Siedner MJ, Sie A, Bountogo M, Ouermi L, Coulibaly B, Bärnighausen T. Depressive symptoms and cardiovascular disease: a population-based study of older adults in rural Burkina Faso. BMJ Open 2020;10:e038199. [PMID: 33371016 DOI: 10.1136/bmjopen-2020-038199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Tsai SY, Shen RS, Kuo CJ, Chen PH, Chung KH, Hsiao CY, Huang SH. The association between carotid atherosclerosis and treatment with lithium and antipsychotics in patients with bipolar disorder. Aust N Z J Psychiatry 2020;54:1125-34. [PMID: 32900219 DOI: 10.1177/0004867420952551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Stubbs B, Mueller C, Gaughran F, Lally J, Vancampfort D, Lamb SE, Koyanagi A, Sharma S, Stewart R, Perera G. Predictors of falls and fractures leading to hospitalization in people with schizophrenia spectrum disorder: A large representative cohort study. Schizophr Res 2018;201:70-8. [PMID: 29793816 DOI: 10.1016/j.schres.2018.05.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
78 Bartoli F, Misiak B, Crocamo C, Carrà G. Glial and neuronal markers in bipolar disorder: A meta-analysis testing S100B and NSE peripheral blood levels. Prog Neuropsychopharmacol Biol Psychiatry 2020;101:109922. [PMID: 32171903 DOI: 10.1016/j.pnpbp.2020.109922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
79 Chen P, Chang C, Chiang S, Lin Y, Tsai S, Huang S. Diabetes mellitus and first episode mania associated with cardiovascular diseases in patients with older-age bipolar disorder. Psychiatry Research 2017;249:65-9. [DOI: 10.1016/j.psychres.2017.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
80 Banihashemi N, Robillard R, Yang J, Carpenter JS, Hermens DF, Naismith SL, Terpening Z, White D, Scott EM, Hickie IB. Quantifying the effect of body mass index, age, and depression severity on 24-h activity patterns in persons with a lifetime history of affective disorders. BMC Psychiatry 2016;16:317. [PMID: 27612556 DOI: 10.1186/s12888-016-1023-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
81 Broderick J, Vancampfort D. Yoga as part of a package of care versus non-standard care for schizophrenia. Cochrane Database Syst Rev 2019;4:CD012807. [PMID: 30990224 DOI: 10.1002/14651858.CD012807.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
82 Lewis M, Chondros P, Mihalopoulos C, Lee YY, Gunn JM, Harvey C, Furler J, Osborn D, Castle D, Davidson S, Jayaram M, Kenny A, Nelson MR, Morgan VA, Harrap S, McKenzie K, Potiriadis M, Densley K, Palmer VJ. The assertive cardiac care trial: A randomised controlled trial of a coproduced assertive cardiac care intervention to reduce absolute cardiovascular disease risk in people with severe mental illness in the primary care setting. Contemp Clin Trials 2020;97:106143. [PMID: 32931919 DOI: 10.1016/j.cct.2020.106143] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Delacrétaz A, Glatard A, Dubath C, Gholam M, Gamma F, von Gunten A, Conus P, Eap CB. Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric population. Basic Clin Pharmacol Toxicol 2021;129:26-35. [PMID: 33733594 DOI: 10.1111/bcpt.13580] [Reference Citation Analysis]
84 Jaakkola J, Teppo K, Biancari F, Halminen O, Putaala J, Mustonen P, Haukka J, Linna M, Kinnunen J, Tiili P, Aro AL, Hartikainen J, Airaksinen KEJ, Lehto M. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: The FinACAF Study. Eur Heart J Qual Care Clin Outcomes 2021:qcab077. [PMID: 34677571 DOI: 10.1093/ehjqcco/qcab077] [Reference Citation Analysis]
85 Calip GS, Xing S, Jun DH, Lee WJ, Hoskins KF, Ko NY. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer. J Oncol Pract 2017;13:e451-62. [PMID: 28287854 DOI: 10.1200/JOP.2016.018317] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
86 van der Lee APM, Hoogendoorn A, de Haan L, Beekman ATF. Discontinuity of psychiatric care for patients with schizophrenia, relation to previous psychiatric care and practice variation between providers: a retrospective longitudinal cohort study. BMC Psychiatry 2021;21:319. [PMID: 34187433 DOI: 10.1186/s12888-021-03319-7] [Reference Citation Analysis]
87 Wu CS, Wu KY, Lo YR, Huang YW, Tsai YT, Li Y, Tsai HJ. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study. J Affect Disord 2018;226:77-84. [PMID: 28964996 DOI: 10.1016/j.jad.2017.09.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
88 Salazar de Pablo G, De Micheli A, Nieman DH, Correll CU, Kessing LV, Pfennig A, Bechdolf A, Borgwardt S, Arango C, van Amelsvoort T, Vieta E, Solmi M, Oliver D, Catalan A, Verdino V, Di Maggio L, Bonoldi I, Vaquerizo-Serrano J, Baccaredda Boy O, Provenzani U, Ruzzi F, Calorio F, Nosari G, Di Marco B, Famularo I, Molteni S, Filosi E, Mensi M, Balottin U, Politi P, Shin JI, Fusar-Poli P. Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis. Eur Neuropsychopharmacol 2020;41:28-39. [PMID: 33162291 DOI: 10.1016/j.euroneuro.2020.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
89 Hui CLM, Lam BST, Lee EHM, Chan SKW, Chang WC, Suen YN, Chen EYH. A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia. Int Rev Psychiatry 2019;31:441-59. [PMID: 31225767 DOI: 10.1080/09540261.2019.1613965] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
90 van der Lee A, de Haan L, Beekman A. Schizophrenia in the Netherlands: Continuity of Care with Better Quality of Care for Less Medical Costs. PLoS One 2016;11:e0157150. [PMID: 27275609 DOI: 10.1371/journal.pone.0157150] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
91 Holper L, Ben-Shachar D, Mann JJ. Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models. Eur Neuropsychopharmacol 2019;29:986-1002. [PMID: 31320210 DOI: 10.1016/j.euroneuro.2019.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Burghardt KJ, Ward KM, Sanders EJ, Howlett BH, Seyoum B, Yi Z. Atypical Antipsychotics and the Human Skeletal Muscle Lipidome. Metabolites 2018;8:E64. [PMID: 30322152 DOI: 10.3390/metabo8040064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
93 Nakanishi M, Tanaka S, Kurokawa G, Ando S, Yamasaki S, Fukuda M, Takahashi K, Kojima T, Nishida A. Inhibited autonomy for promoting physical health: qualitative analysis of narratives from persons living with severe mental illness. BJPsych Open 2019;5:e10. [PMID: 30762505 DOI: 10.1192/bjo.2018.77] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
94 Fu T, Liu X, Liu J, Cai E, Zhao Y, Li H, Zhang L, Li P, Gao Y. α-Mangostin exhibits antidepressant-like effects mediated by the modification of GABAergic, serotonergic and dopaminergic systems. Nat Prod Res 2020;34:868-71. [PMID: 30417675 DOI: 10.1080/14786419.2018.1503659] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
95 Angeler DG, Chaffin BC, Sundstrom SM, Garmestani A, Pope KL, Uden DR, Twidwell D, Allen CR. Coerced regimes: management challenges in the Anthropocene. Ecol Soc 2020;25:1-4. [PMID: 32523609 DOI: 10.5751/es-11286-250104] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
96 Elie D, Marino A, Torres-Platas SG, Noohi S, Semeniuk T, Segal M, Looper KJ, Rej S. End-of-Life Care Preferences in Patients with Severe and Persistent Mental Illness and Chronic Medical Conditions: A Comparative Cross-Sectional Study. Am J Geriatr Psychiatry 2018;26:89-97. [PMID: 29066037 DOI: 10.1016/j.jagp.2017.09.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
97 Rice JN, Gillett CB, Malas NM. The Impact of Psychotropic Medications on Bone Health in Youth. Curr Psychiatry Rep 2018;20:104. [PMID: 30246221 DOI: 10.1007/s11920-018-0960-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
98 Stubbs B, Vancampfort D, Mänty M, Svärd A, Rahkonen O, Lahti J. Bidirectional longitudinal relationship between leisure-time physical activity and psychotropic medication usage: A register linked follow-up study. Psychiatry Research 2017;247:208-13. [DOI: 10.1016/j.psychres.2016.11.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
99 Kahl KG, Westhoff-bleck M, Krüger TH. Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system. Vascular Pharmacology 2018;100:20-5. [DOI: 10.1016/j.vph.2017.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
100 Avrahami M, Peskin M, Moore T, Drapisz A, Taylor J, Segal-Gavish H, Balan-Moshe L, Shachar I, Levy T, Weizman A, Barzilay R. Body mass index increase in preschoolers with heterogeneous psychiatric diagnoses treated with risperidone. J Psychopharmacol 2021;:2698811211008592. [PMID: 33892604 DOI: 10.1177/02698811211008592] [Reference Citation Analysis]
101 Mansur RB, Rizzo LB, Santos CM, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni M, Cordeiro Q, Mcintyre RS, Brietzke E. Adipokines, metabolic dysfunction and illness course in bipolar disorder. Journal of Psychiatric Research 2016;74:63-9. [DOI: 10.1016/j.jpsychires.2015.12.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
102 Chen PH, Tsai SY, Pan CH, Chang HM, Chen YL, Su SS, Chen CC, Kuo CJ. Incidence and risk factors of sudden cardiac death in bipolar disorder across the lifespan. J Affect Disord 2020;274:210-7. [PMID: 32469806 DOI: 10.1016/j.jad.2020.05.094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Delacrétaz A, Glatard A, Dubath C, Gholam-Rezaee M, Sanchez-Mut JV, Gräff J, von Gunten A, Conus P, Eap CB. Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients. Clin Epigenetics 2019;11:198. [PMID: 31878957 DOI: 10.1186/s13148-019-0792-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
104 Verdoux H, Pambrun E, Tournier M, Cortaredona S, Verger P. Multi‐trajectories of antidepressant and antipsychotic use: a 11‐year naturalistic study in a community‐based sample. Acta Psychiatr Scand 2019;139:536-47. [DOI: 10.1111/acps.13020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
105 Chen PH, Kao YH, Chang CK, Lin YK, Lin YF, Chen YJ. Clinical Risk Factors for Therapeutic Lithium-Associated Electrocardiographic Changes in Patients With Bipolar Disorder. J Clin Psychopharmacol 2020;40:46-53. [PMID: 31834090 DOI: 10.1097/JCP.0000000000001164] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
106 Stubbs B, Koyanagi A, Veronese N, Vancampfort D, Solmi M, Gaughran F, Carvalho AF, Lally J, Mitchell AJ, Mugisha J, Correll CU. Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries. BMC Med 2016;14:189. [PMID: 27871281 DOI: 10.1186/s12916-016-0734-z] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 13.2] [Reference Citation Analysis]
107 Vancampfort D, Probst M, Basangwa D, De Hert M, Myin-Germeys I, van Winkel R, Ward PB, Rosenbaum S, Mugisha J. Adherence to physical activity recommendations and physical and mental health risk in people with severe mental illness in Uganda. Psychiatry Res 2018;260:236-40. [PMID: 29220680 DOI: 10.1016/j.psychres.2017.11.067] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
108 Rosenblat JD, Mcintyre RS. Pharmacological Approaches to Minimizing Cardiometabolic Side Effects of Mood Stabilizing Medications. Curr Treat Options Psych 2017;4:319-32. [DOI: 10.1007/s40501-017-0131-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Ghani M, Kuruppu S, Pritchard M, Harris M, Weerakkody R, Stewart R, Perera G. Vascular surgery receipt and outcomes for people with serious mental illnesses: Retrospective cohort study using a large mental healthcare database in South London. J Psychosom Res 2021;147:110511. [PMID: 34051514 DOI: 10.1016/j.jpsychores.2021.110511] [Reference Citation Analysis]
110 de Silva VA, Dayabandara M, Wijesundara H, Henegama T, Gunewardena H, Suraweera C, Hanwella R. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study. J Psychopharmacol 2015;29:1255-61. [PMID: 26510448 DOI: 10.1177/0269881115613519] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
111 Lahijani SC, Harris KA. Medical Complications of Psychiatric Treatment: An Update. Crit Care Clin 2017;33:713-34. [PMID: 28601142 DOI: 10.1016/j.ccc.2017.03.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
112 Amerio A, Ossola P, Scagnelli F, Odone A, Allinovi M, Cavalli A, Iacopelli J, Tonna M, Marchesi C, Ghaemi S. Safety and efficacy of lithium in children and adolescents: A systematic review in bipolar illness. Eur psychiatr 2018;54:85-97. [DOI: 10.1016/j.eurpsy.2018.07.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
113 Chen PH, Chiang SJ, Hsiao CY, Shen RS, Lin YK, Chung KH, Tsai SY. Echocardiographic study of cardiac structure and function in people with bipolar disorder after midlife. J Affect Disord 2022;296:428-33. [PMID: 34606806 DOI: 10.1016/j.jad.2021.09.089] [Reference Citation Analysis]
114 Bartoli F, Di Brita C, Crocamo C, Clerici M, Carrà G. Lipid profile and suicide attempt in bipolar disorder: A meta-analysis of published and unpublished data. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2017;79:90-5. [DOI: 10.1016/j.pnpbp.2017.06.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
115 Delacrétaz A, Zdralovic A, Vandenberghe F, Saigi-morgui N, Glatard A, Quteineh L, Gholam-rezaee M, Raffoul W, Applegate LA, Jafari P, Gamma F, von Gunten A, Conus P, Eap CB. Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs. Gene 2017;628:8-15. [DOI: 10.1016/j.gene.2017.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
116 Kim SW, Park WY, Jhon M, Kim M, Lee JY, Kim SY, Kim JM, Shin IS, Yoon JS. Physical Health Literacy and Health-related Behaviors in Patients with Psychosis. Clin Psychopharmacol Neurosci 2019;17:279-87. [PMID: 30905128 DOI: 10.9758/cpn.2019.17.2.279] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
117 Maj M, Stein DJ, Parker G, Zimmerman M, Fava GA, De Hert M, Demyttenaere K, McIntyre RS, Widiger T, Wittchen HU. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry 2020;19:269-93. [PMID: 32931110 DOI: 10.1002/wps.20771] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 13.5] [Reference Citation Analysis]
118 Szabo A, O'Connell KS, Ueland T, Sheikh MA, Agartz I, Andreou D, Aukrust P, Boye B, Bøen E, Drange OK, Elvsåshagen T, Engh JA, Hope S, Collier Høegh M, Joa I, Johnsen E, Kroken RA, Vik Lagerberg T, Lekva T, Malt UF, Melle I, Morken G, Nærland T, Steen VM, Sørensen K, Wedervang-Resell K, Auten Weibell M, Westlye LT, Steen NE, Andreassen O, Djurovic S. Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation. Brain Behav Immun 2021;99:299-306. [PMID: 34758379 DOI: 10.1016/j.bbi.2021.10.017] [Reference Citation Analysis]
119 Dabba K, Elswood M, Ameer A, Gerrett D, Maidment I. A mixed methods analysis of clozapine errors reported to the National Reporting and Learning System. Pharmacoepidemiol Drug Saf 2019;28:657-64. [DOI: 10.1002/pds.4727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
120 Schoretsanitis G, Haen E, Hiemke C, Fay B, Unholzer S, Correll CU, Gründer G, Paulzen M. Sex and body weight are major determinants of venlafaxine pharmacokinetics: . International Clinical Psychopharmacology 2018;33:322-9. [DOI: 10.1097/yic.0000000000000234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
121 Simoons M, Ruhé HG, van Roon EN, Schoevers RA, Bruggeman R, Cath DC, Muis D, Arends J, Doornbos B, Mulder H. Design and methods of the 'monitoring outcomes of psychiatric pharmacotherapy' (MOPHAR) monitoring program - a study protocol. BMC Health Serv Res 2019;19:125. [PMID: 30764821 DOI: 10.1186/s12913-019-3951-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Hosang GM, Fisher HL, Uher R, Cohen-Woods S, Maughan B, McGuffin P, Farmer AE. Childhood maltreatment and the medical morbidity in bipolar disorder: a case-control study. Int J Bipolar Disord 2017;5:30. [PMID: 28879470 DOI: 10.1186/s40345-017-0099-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
123 Charles EF, Lambert CG, Kerner B. Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications. Int J Bipolar Disord 2016;4:13. [PMID: 27389787 DOI: 10.1186/s40345-016-0054-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
124 Højlund M, Pottegård A, Johnsen E, Kroken RA, Reutfors J, Munk-Jørgensen P, Correll CU. Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016. Br J Clin Pharmacol 2019;85:1598-606. [PMID: 30927284 DOI: 10.1111/bcp.13945] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
125 Delacrétaz A, Lagares Santos P, Saigi Morgui N, Vandenberghe F, Glatard A, Gholam-Rezaee M, von Gunten A, Conus P, Eap CB. Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs. Pharmacogenet Genomics 2017;27:464-72. [PMID: 28945215 DOI: 10.1097/FPC.0000000000000313] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
126 Calabrese JR, Jin N, Johnson B, Such P, Baker RA, Madera J, Hertel P, Ottinger J, Amatniek J, Kawasaki H. Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study. Int J Bipolar Disord 2018;6:14. [PMID: 29886522 DOI: 10.1186/s40345-018-0122-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
127 Kritharides L, Chow V, Lambert TJ. Cardiovascular disease in patients with schizophrenia. Medical Journal of Australia 2017;206:91-5. [DOI: 10.5694/mja16.00650] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
128 Dries SS, Seibert BS, Bastiani MF, Linden R, Perassolo MS. Evaluation of oxidative stress biomarkers and liver and renal functional parameters in patients during treatment a mental health unit to treat alcohol dependence. Drug Chem Toxicol 2020;:1-7. [PMID: 32567384 DOI: 10.1080/01480545.2020.1780251] [Reference Citation Analysis]
129 Chen PH, Lin YK, Chang CK, Chiang SJ, Tsai SY. Dysregulation of glucose metabolism since young adulthood increases the risk of cardiovascular diseases in patients with bipolar disorder. Kaohsiung J Med Sci 2017;33:630-6. [PMID: 29132553 DOI: 10.1016/j.kjms.2017.07.005] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
130 Sud D, Laughton E, Mcaskill R, Bradley E, Maidment I. The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review. Syst Rev 2021;10. [DOI: 10.1186/s13643-021-01586-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Fountoulakis KN, Moeller H, Kasper S, Tamminga C, Yamawaki S, Kahn R, Tandon R, Correll CU, Javed A. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. CNS Spectr . [DOI: 10.1017/s1092852920001546] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Vancampfort D, Rosenbaum S, Schuch FB, Ward PB, Probst M, Stubbs B. Prevalence and predictors of treatment dropout from physical activity interventions in schizophrenia: a meta-analysis. Gen Hosp Psychiatry 2016;39:15-23. [PMID: 26719106 DOI: 10.1016/j.genhosppsych.2015.11.008] [Cited by in Crossref: 108] [Cited by in F6Publishing: 100] [Article Influence: 15.4] [Reference Citation Analysis]
133 Stubbs B, Wang AK, Vancampfort D, Miller BJ. Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis. Psychoneuroendocrinology 2016;63:144-54. [DOI: 10.1016/j.psyneuen.2015.09.026] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
134 Hálfdánarson Ó, Zoëga H, Aagaard L, Bernardo M, Brandt L, Fusté AC, Furu K, Garuoliené K, Hoffmann F, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Litchfield M, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Pearson SA, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Skurtveit S, Verdoux H, Wang LJ, Yahni CZ, Bachmann CJ. International trends in antipsychotic use: A study in 16 countries, 2005-2014. Eur Neuropsychopharmacol 2017;27:1064-76. [PMID: 28755801 DOI: 10.1016/j.euroneuro.2017.07.001] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 18.0] [Reference Citation Analysis]
135 Copeli F, Cohen CI. Medical Issues in Older Adults with Schizophrenia. In: Cohen CI, Meesters PD, editors. Schizophrenia and Psychoses in Later Life. Cambridge University Press; 2019. pp. 79-94. [DOI: 10.1017/9781108539593.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Gurusamy J, Gandhi S, Damodharan D, Palaniappan M, Venkatasubramanian G. Grounded theory of 'lifestyle adaptation' - Perspectives from persons with schizophrenia and their caregivers. Asian J Psychiatr 2021;56:102511. [PMID: 33412371 DOI: 10.1016/j.ajp.2020.102511] [Reference Citation Analysis]
137 Teppo K, Jaakkola J, Lehto M, Biancari F, Airaksinen KEJ. The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis. Am J Prev Cardiol 2021;7:100221. [PMID: 34611647 DOI: 10.1016/j.ajpc.2021.100221] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Ersland KM, Myrmel LS, Fjære E, Berge RK, Madsen L, Steen VM, Skrede S. One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects. Int J Neuropsychopharmacol 2019;22:358-69. [PMID: 30854556 DOI: 10.1093/ijnp/pyz012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
139 Kahl KG, Westhoff-bleck M, Krüger TH. Effects of psychopharmacological treatment with antidepressants on the vascular system. Vascular Pharmacology 2017;96-98:11-8. [DOI: 10.1016/j.vph.2017.07.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
140 Schneider F, Erhart M, Hewer W, Loeffler LA, Jacobi F. Mortality and Medical Comorbidity in the Severely Mentally Ill. Dtsch Arztebl Int 2019;116:405-11. [PMID: 31366432 DOI: 10.3238/arztebl.2019.0405] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
141 Chen LX, Qi Z, Shao ZJ, Li SS, Qi YL, Gao K, Liu SX, Li Z, Sun YS, Li PY. Study on Antidepressant Activity of Pseudo-Ginsenoside HQ on Depression-Like Behavior in Mice. Molecules 2019;24:E870. [PMID: 30823679 DOI: 10.3390/molecules24050870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
142 Oedegaard CH, Davidson L, Stige B, Veseth M, Blindheim A, Garvik L, Sørensen JM, Søraa Ø, Engebretsen IMS. "It means so much for me to have a choice": a qualitative study providing first-person perspectives on medication-free treatment in mental health care. BMC Psychiatry 2020;20:399. [PMID: 32770965 DOI: 10.1186/s12888-020-02770-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
143 Foguet-Boreu Q, Fernandez San Martin MI, Flores Mateo G, Zabaleta Del Olmo E, Ayerbe García-Morzon L, Perez-Piñar López M, Martin-López LM, Montes Hidalgo J, Violán C. Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysis. BMC Psychiatry 2016;16:141. [PMID: 27176477 DOI: 10.1186/s12888-016-0833-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
144 Esposito CM, Ceresa A, Buoli M. The Association Between Personality Traits and Dietary Choices: A Systematic Review. Adv Nutr 2021;12:1149-59. [PMID: 33427288 DOI: 10.1093/advances/nmaa166] [Reference Citation Analysis]
145 Çelik Ince S, Partlak Günüşen N, Serçe Ö. Perception of physical health by patients with severe mental illness and their family caregivers: A qualitative study. Perspect Psychiatr Care 2019;55:718-27. [PMID: 31292971 DOI: 10.1111/ppc.12416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
146 Asmelash D, Getnet W, Biadgo B, Ambachew S, Melak T, Melese L, Damite S, Baynes HW, Abebe M. Undiagnosed Diabetes Mellitus and Associated Factors among Psychiatric Patients Receiving Antipsychotic Drugs at The University of Gondar Hospital, Northwest Ethiopia. Ethiop J Health Sci 2018;28:3-10. [PMID: 29622902 DOI: 10.4314/ejhs.v28i1.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
147 Cortese S, Solmi M, Arrondo G, Cipriani A, Fusar-poli P, Larsson H, Correll C. Association between mental disorders and somatic conditions: protocol for an umbrella review. Evid Based Mental Health 2020;23:135-9. [DOI: 10.1136/ebmental-2020-300158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
148 Zhao Y, Wen SW, Li M, Sun Z, Yuan X, Retnakaran R, Zhang R, Zhai D. Dose-response association of acute-phase quetiapine treatment with risk of new-onset hypothyroidism in schizophrenia patients. Br J Clin Pharmacol 2021. [PMID: 34046922 DOI: 10.1111/bcp.14928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Seeman MV. Psychosis and Physical Comorbidity. In: Chandra P, Herrman H, Fisher J, Riecher-rössler A, editors. Mental Health and Illness of Women. Singapore: Springer; 2019. pp. 1-28. [DOI: 10.1007/978-981-10-0371-4_20-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
150 Antoine B, Nicolas D, Laurent D. Reshaping Community Mental Health Services during the COVID-19 Epidemic - Report from the 59G21 Service in Lille, France. Health Serv Insights 2020;13:1178632920954876. [PMID: 32973373 DOI: 10.1177/1178632920954876] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
151 Cepaityte D, Siafis S, Egberts T, Leucht S, Kouvelas D, Papazisis G. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study. Schizophr Bull 2021;47:672-81. [PMID: 33289848 DOI: 10.1093/schbul/sbaa163] [Reference Citation Analysis]
152 Ashour AA, Basha S, Enan ET, Basalem A, Qahatani AA. Association between obesity/overweight and dental caries in psychiatric patients. Ann Saudi Med 2019;39:178-84. [PMID: 31215224 DOI: 10.5144/0256-4947.2019.178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
153 Carvalho Henriques B, Yang EH, Lapetina D, Carr MS, Yavorskyy V, Hague J, Aitchison KJ. How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing? Front Genet 2020;11:491895. [PMID: 33363564 DOI: 10.3389/fgene.2020.491895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
154 Gaughran F, Stahl D, Ismail K, Greenwood K, Atakan Z, Gardner-Sood P, Stubbs B, Hopkins D, Patel A, Lally J, Lowe P, Arbuthnot M, Orr D, Corlett S, Eberhard J, David AS, Murray R, Smith S; IMPaCT Team. Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT). BMC Psychiatry 2017;17:413. [PMID: 29284438 DOI: 10.1186/s12888-017-1571-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
155 Huang KL, Chen MH, Hsu JW, Tsai SJ, Bai YM. Using classification and regression tree modeling to investigate appetite hormones and proinflammatory cytokines as biomarkers to differentiate bipolar I depression from major depressive disorder. CNS Spectr 2021;:1-7. [PMID: 33563365 DOI: 10.1017/S109285292100016X] [Reference Citation Analysis]
156 Szabo A, Akkouh IA, Vandenberghe M, Osete JR, Hughes T, Heine V, Smeland OB, Glover JC, Andreassen OA, Djurovic S. A human iPSC-astroglia neurodevelopmental model reveals divergent transcriptomic patterns in schizophrenia. Transl Psychiatry 2021;11:554. [PMID: 34716291 DOI: 10.1038/s41398-021-01681-4] [Reference Citation Analysis]
157 Soontornniyomkij V, Lee EE, Jin H, Martin AS, Daly RE, Liu J, Tu XM, Eyler LT, Jeste DV. Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms. Front Psychiatry 2019;10:251. [PMID: 31065243 DOI: 10.3389/fpsyt.2019.00251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
158 Vancampfort D, Stubbs B, Richards J, Ward PB, Firth J, Schuch FB, Rosenbaum S. Physical fitness in people with posttraumatic stress disorder: a systematic review. Disabil Rehabil 2017;39:2461-7. [PMID: 27628485 DOI: 10.1080/09638288.2016.1226412] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
159 van der Heide D, Boskovic I, Harten P, Merckelbach H. Overlooking Feigning Behavior May Result in Potential Harmful Treatment Interventions: Two Case Reports of Undetected Malingering. J Forensic Sci 2020;65:1371-5. [DOI: 10.1111/1556-4029.14320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
160 Voll SL, Boot E, Butcher NJ, Cooper S, Heung T, Chow EW, Silversides CK, Bassett AS. Obesity in adults with 22q11.2 deletion syndrome. Genet Med 2017;19:204-8. [PMID: 27537705 DOI: 10.1038/gim.2016.98] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
161 McDowell CP, Gordon BR, Andrews KL, MacDonncha C, Herring MP. Associations of physical activity with anxiety symptoms and status: results from The Irish longitudinal study on ageing. Epidemiol Psychiatr Sci 2019;28:436-45. [PMID: 29382402 DOI: 10.1017/S204579601800001X] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 3.8] [Reference Citation Analysis]
162 Lo C, Tsang W, Yan C, Lord S, Hill K, Wong A. Risk factors for falls in patients with total hip arthroplasty and total knee arthroplasty: a systematic review and meta-analysis. Osteoarthritis and Cartilage 2019;27:979-93. [DOI: 10.1016/j.joca.2019.04.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
163 Besag FMC, Vasey MJ, Sharma AN, Lam ICH. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Ther Adv Psychopharmacol 2021;11:20451253211045870. [PMID: 34646439 DOI: 10.1177/20451253211045870] [Reference Citation Analysis]
164 Sheikh MA. Child maltreatment, psychopathological symptoms, and onset of diabetes mellitus, hypothyroidism and COPD in adulthood. Journal of Affective Disorders 2018;241:80-5. [DOI: 10.1016/j.jad.2018.07.085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
165 Andersen E, Bang-Kittilsen G, Bigseth TT, Egeland J, Holmen TL, Martinsen EW, Stensrud T, Engh JA. Effect of high-intensity interval training on cardiorespiratory fitness, physical activity and body composition in people with schizophrenia: a randomized controlled trial. BMC Psychiatry 2020;20:425. [PMID: 32854688 DOI: 10.1186/s12888-020-02827-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
166 Deenik J, Tenback DE, van Driel HF, Tak ECPM, Hendriksen IJM, van Harten PN. Less Medication Use in Inpatients With Severe Mental Illness Receiving a Multidisciplinary Lifestyle Enhancing Treatment. The MULTI Study III. Front Psychiatry 2018;9:707. [PMID: 30618878 DOI: 10.3389/fpsyt.2018.00707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Suvisaari J, Keinänen J, Eskelinen S, Mantere O. Diabetes and Schizophrenia. Curr Diab Rep 2016;16. [DOI: 10.1007/s11892-015-0704-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
168 Thongsai S, Gray R, Bressington D. The physical health of people with schizophrenia in Asia: Baseline findings from a physical health check programme. J Psychiatr Ment Health Nurs 2016;23:255-66. [DOI: 10.1111/jpm.12300] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
169 Stubbs B, Vancampfort D, Hallgren M, Firth J, Veronese N, Solmi M, Brand S, Cordes J, Malchow B, Gerber M, Schmitt A, Correll CU, De Hert M, Gaughran F, Schneider F, Kinnafick F, Falkai P, Möller HJ, Kahl KG. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH). Eur Psychiatry 2018;54:124-44. [PMID: 30257806 DOI: 10.1016/j.eurpsy.2018.07.004] [Cited by in Crossref: 156] [Cited by in F6Publishing: 131] [Article Influence: 52.0] [Reference Citation Analysis]
170 Keks N, Schwartz D, Hope J. Stopping and switching antipsychotic drugs. Aust Prescr 2019;42:152-7. [PMID: 31631928 DOI: 10.18773/austprescr.2019.052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
171 Burghardt KJ, Howlett BH, Sanders E, Dass SE, Msallaty Z, Mallisho A, Seyoum B, Yi Z. Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder. Eur Neuropsychopharmacol 2019;29:1365-73. [PMID: 31635791 DOI: 10.1016/j.euroneuro.2019.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
172 Lange-Asschenfeldt C. [Psychiatric pharmacotherapy of older individuals with severe mental illness]. Z Gerontol Geriatr 2018;51:770-8. [PMID: 30302537 DOI: 10.1007/s00391-018-1455-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Hosang GM, Fisher HL, Hodgson K, Maughan B, Farmer AE. Childhood maltreatment and adult medical morbidity in mood disorders: comparison of unipolar depression with bipolar disorder. Br J Psychiatry 2018;213:645-53. [PMID: 30232950 DOI: 10.1192/bjp.2018.178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
174 Breland JY, Frayne SM, Timko C, Washington DL, Maguen S. Mental Health and Obesity Among Veterans: A Possible Need for Integrated Care. Psychiatr Serv 2020;71:506-9. [PMID: 31996116 DOI: 10.1176/appi.ps.201900078] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
175 Sun L, Getz M, Daboul S, Jay M, Sherman S, Rogers E, Aujero N, Rosedale M, Goetz RR, Weissman J, Malaspina D, Ahmad S. Independence of diabetes and obesity in adults with serious mental illness: Findings from a large urban public hospital. Journal of Psychiatric Research 2018;99:159-66. [DOI: 10.1016/j.jpsychires.2018.01.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
176 Mugisha J, De Hert M, Stubbs B, Basangwa D, Vancampfort D. Physical health policies and metabolic screening in mental health care systems of sub-Saharan African countries: a systematic review. Int J Ment Health Syst 2017;11:31. [PMID: 28428816 DOI: 10.1186/s13033-017-0141-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
177 Folch A, Salvador‐carulla L, Vicens P, Cortés MJ, Irazábal M, Muñoz S, Rovira L, Orejuela C, González JA, Martínez‐leal R. Health indicators in intellectual developmental disorders: The key findings of the POMONAESP project. J Appl Res Intellect Disabil 2019;32:23-34. [DOI: 10.1111/jar.12498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
178 Swartz HA, Rucci P, Thase ME, Wallace M, Carretta E, Celedonia KL, Frank E. Psychotherapy Alone and Combined With Medication as Treatments for Bipolar II Depression: A Randomized Controlled Trial. J Clin Psychiatry 2018;79:16m11027. [PMID: 28703949 DOI: 10.4088/JCP.16m11027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 4.7] [Reference Citation Analysis]
179 Rajamani U, Gross AR, Hjelm BE, Sequeira A, Vawter MP, Tang J, Gangalapudi V, Wang Y, Andres AM, Gottlieb RA, Sareen D. Super-Obese Patient-Derived iPSC Hypothalamic Neurons Exhibit Obesogenic Signatures and Hormone Responses. Cell Stem Cell 2018;22:698-712.e9. [PMID: 29681516 DOI: 10.1016/j.stem.2018.03.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
180 Nielsen RE, Kugathasan P, Straszek S, Jensen SE, Licht RW. Why are somatic diseases in bipolar disorder insufficiently treated? Int J Bipolar Disord 2019;7:12. [PMID: 31055668 DOI: 10.1186/s40345-019-0147-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
181 Yin Y, Liu X, Liu J, Cai E, Zhao Y, Li H, Zhang L, Li P, Gao Y. The effect of beta-sitosterol and its derivatives on depression by the modification of 5-HT, DA and GABA-ergic systems in mice. RSC Adv 2018;8:671-80. [DOI: 10.1039/c7ra11364a] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
182 Scorza FA, Almeida AG, Scorza CA, Moret MA, Finsterer J. Bipolar Disorder: The Vitamin D Debate. J Affect Disord 2021;286:338-9. [PMID: 33773216 DOI: 10.1016/j.jad.2021.02.073] [Reference Citation Analysis]
183 Kanba S, Murasaki M, Koyama T, Takeuchi M, Shimizu Y, Arita E, Kuroishi K, Takeuchi M, Kamei S. Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression. BMC Psychiatry 2019;19:198. [PMID: 31242884 DOI: 10.1186/s12888-019-2181-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
184 Rødevand L, Bahrami S, Frei O, Chu Y, Shadrin A, O'Connell KS, Smeland OB, Elvsåshagen T, Hindley GFL, Djurovic S, Dale AM, Lagerberg TV, Steen NE, Andreassen OA. Extensive bidirectional genetic overlap between bipolar disorder and cardiovascular disease phenotypes. Transl Psychiatry 2021;11:407. [PMID: 34301917 DOI: 10.1038/s41398-021-01527-z] [Reference Citation Analysis]
185 Mitchell AJ, De Hert M. Promotion of physical health in persons with schizophrenia: can we prevent cardiometabolic problems before they begin? Acta Psychiatr Scand 2015;132:83-5. [PMID: 26177260 DOI: 10.1111/acps.12466] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
186 Hochman L, Moran GS, Gelkopf M, Roe D, Shadmi E. Prospectively identifying adults with serious mental illness at risk for poor physical health: The role of person reported outcomes. Int J Qual Health Care 2021;33:mzaa033. [PMID: 32296822 DOI: 10.1093/intqhc/mzaa033] [Reference Citation Analysis]
187 Wang W, Liu X, Liu J, Cai E, Zhao Y, Li H, Zhang L, Li P, Gao Y. Sesquiterpenoids from the Root of Panax ginseng Attenuates Lipopolysaccharide-Induced Depressive-Like Behavior through the Brain-Derived Neurotrophic Factor/Tropomyosin-Related Kinase B and Sirtuin Type 1/Nuclear Factor-κB Signaling Pathways. J Agric Food Chem 2018;66:265-71. [DOI: 10.1021/acs.jafc.7b04835] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
188 Chang J, Kim JA, Kim K, Choi S, Kim SM, Nam YY, Park S, Goo AJ, Park SM. Association of antipsychotics adherence and cardiovascular disease among newly diagnosed schizophrenia patients: A national cohort among Koreans. Asian J Psychiatr 2020;52:102161. [PMID: 32454424 DOI: 10.1016/j.ajp.2020.102161] [Reference Citation Analysis]
189 Mansur RB, Rizzo LB, Santos CM, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni M, Cordeiro Q, McIntyre RS, Brietzke E. Impaired glucose metabolism moderates the course of illness in bipolar disorder. J Affect Disord 2016;195:57-62. [PMID: 26866976 DOI: 10.1016/j.jad.2016.02.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
190 Højlund M, Lund LC, Herping JLE, Haastrup MB, Damkier P, Henriksen DP. Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study. BMJ Open 2020;10:e038247. [PMID: 32784262 DOI: 10.1136/bmjopen-2020-038247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
191 González-Rodríguez A, Seeman MV. Pharmacotherapy for schizophrenia in postmenopausal women. Expert Opin Pharmacother 2018;19:809-21. [PMID: 29676942 DOI: 10.1080/14656566.2018.1465563] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
192 Marshe VS, Pira S, Mantere O, Bosche B, Looper KJ, Herrmann N, Müller DJ, Rej S. C-reactive protein and cardiovascular risk in bipolar disorder patients: A systematic review. Prog Neuropsychopharmacol Biol Psychiatry 2017;79:442-51. [PMID: 28764912 DOI: 10.1016/j.pnpbp.2017.07.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
193 Rubio JM, Correll CU. Reduced all-cause mortality with antipsychotics and antidepressants compared to increased all-cause mortality with benzodiazepines in patients with schizophrenia observed in naturalistic treatment settings. Evid Based Ment Health 2017;20:e6. [PMID: 28096176 DOI: 10.1136/eb-2016-102525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
194 Hallam KT, Bilsborough S, de Courten M. "Happy feet": evaluating the benefits of a 100-day 10,000 step challenge on mental health and wellbeing. BMC Psychiatry 2018;18:19. [PMID: 29361921 DOI: 10.1186/s12888-018-1609-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
195 Broderick J, Vancampfort D. Yoga as part of a package of care versus standard care for schizophrenia. Cochrane Database Syst Rev 2017;9:CD012145. [PMID: 28960019 DOI: 10.1002/14651858.CD012145.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
196 O'Brien AJ, Abraham RM. Evaluation of metabolic monitoring practices for mental health consumers in the Southern District Health Board Region of New Zealand. J Psychiatr Ment Health Nurs 2020. [PMID: 33382181 DOI: 10.1111/jpm.12729] [Reference Citation Analysis]
197 Tréhout M, Dollfus S. [Physical activity in patients with schizophrenia: From neurobiology to clinical benefits]. Encephale 2018;44:538-47. [PMID: 29983176 DOI: 10.1016/j.encep.2018.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Šimunović Filipčić I, Ivezić E, Jakšić N, Mayer N, Grah M, Rojnić Kuzman M, Bajić Z, Svab V, Herceg M, Filipčić I. Gender differences in early onset of chronic physical multimorbidities in schizophrenia spectrum disorder: Do women suffer more? Early Intervention in Psychiatry 2020;14:418-27. [DOI: 10.1111/eip.12867] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
199 Zhuo C, Li G, Lin X, Jiang D, Xu Y, Tian H, Wang W, Song X. Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review. Brain Imaging Behav 2021;15:1115-33. [PMID: 32304018 DOI: 10.1007/s11682-020-00284-9] [Reference Citation Analysis]
200 Tham M, Chong TWH, Jenkins ZM, Castle DJ. The use of anti-obesity medications in people with mental illness as an adjunct to lifestyle interventions - Effectiveness, tolerability and impact on eating behaviours: A 52-week observational study. Obes Res Clin Pract 2021;15:49-57. [PMID: 33257207 DOI: 10.1016/j.orcp.2020.11.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
201 Manchia M, Firinu G, Carpiniello B, Pinna F. Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness. BMC Psychiatry 2017;17:121. [PMID: 28359306 DOI: 10.1186/s12888-017-1289-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
202 Krogmann A, Peters L, von Hardenberg L, Bödeker K, Nöhles VB, Correll CU. Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities. CNS Spectr 2019;24:38-69. [PMID: 31482779 DOI: 10.1017/S109285291900124X] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 16.5] [Reference Citation Analysis]
203 Taylor J, Siddiqi N. Improving health outcomes for adults with severe mental illness and comorbid diabetes: is supporting diabetes self-management the right approach? J Psychiatr Ment Health Nurs 2016;23:322-30. [DOI: 10.1111/jpm.12307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
204 Ma R, Romano E, Davis K, Stewart R, Ashworth M, Vancampfort D, Gaughran F, Stubbs B, Mueller C. Osteoporosis referral and treatment among people with severe mental illness: A ten-year data linkage study. J Psychiatr Res 2022;147:94-102. [PMID: 35030512 DOI: 10.1016/j.jpsychires.2022.01.005] [Reference Citation Analysis]
205 Ivanov SV, Voronova EI. [Depression therapy for somatic diseases]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:106-12. [PMID: 34405665 DOI: 10.17116/jnevro2021121052106] [Reference Citation Analysis]
206 Kilicaslan EE, Karakilic M, Erol A. The Relationship between 10 Years Risk of Cardiovascular Disease and Schizophrenia Symptoms: Preliminary Results. Psychiatry Investig 2019;16:933-9. [PMID: 31801314 DOI: 10.30773/pi.2019.0063] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
207 Salvi V, Mencacci C, Barone-Adesi F. H1-histamine receptor affinity predicts weight gain with antidepressants. Eur Neuropsychopharmacol 2016;26:1673-7. [PMID: 27593622 DOI: 10.1016/j.euroneuro.2016.08.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
208 Reutfors J, Brenner P, Brody B, Wray H, Andersen M, Brandt L. A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case-Control Analyses of Select Outcomes. Drug Saf 2020;43:135-45. [PMID: 31848933 DOI: 10.1007/s40264-019-00889-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
209 Stanton R, Rosenbaum S, Rebar A, Happell B. Prevalence of Chronic Health Conditions in Australian Adults with Depression and/or Anxiety. Issues Ment Health Nurs 2019;40:902-7. [PMID: 31283353 DOI: 10.1080/01612840.2019.1613701] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
210 Zhao Y, Wen SW, Qin Y, Liu Y, Gao Y, Retnakaran R, Zhang R, Zhai D. Association between valproate treatment for acute phase schizophrenia and risk of new onset hypothyroidism. Schizophr Res 2021;235:12-6. [PMID: 34298238 DOI: 10.1016/j.schres.2021.07.011] [Reference Citation Analysis]
211 Stubbs B, Koyanagi A, Schuch F, Firth J, Rosenbaum S, Gaughran F, Mugisha J, Vancampfort D. Physical Activity Levels and Psychosis: A Mediation Analysis of Factors Influencing Physical Activity Target Achievement Among 204 186 People Across 46 Low- and Middle-Income Countries. Schizophr Bull 2017;43:536-45. [PMID: 27562855 DOI: 10.1093/schbul/sbw111] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
212 Nakamura ZM, Nash RP, Laughon SL, Rosenstein DL. Neuropsychiatric Complications of COVID-19. Curr Psychiatry Rep 2021;23:25. [PMID: 33725218 DOI: 10.1007/s11920-021-01237-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
213 Szabo A, Akkouh IA, Ueland T, Lagerberg TV, Dieset I, Bjella T, Aukrust P, Le Hellard S, Stavrum AK, Melle I, Andreassen OA, Djurovic S. Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder. Front Psychiatry 2020;11:642. [PMID: 32714224 DOI: 10.3389/fpsyt.2020.00642] [Reference Citation Analysis]
214 Lambert M, Ruppelt F, Siem A, Rohenkohl AC, Kraft V, Luedecke D, Sengutta M, Schröter R, Daubmann A, Correll CU, Gallinat J, Karow A, Wiedemann K, Schöttle D. Comorbidity of chronic somatic diseases in patients with psychotic disorders and their influence on 4-year outcomes of integrated care treatment (ACCESS II study). Schizophrenia Research 2018;193:377-83. [DOI: 10.1016/j.schres.2017.07.036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
215 Bernardi J, Aromolaran KA, Aromolaran AS. Neurological Disorders and Risk of Arrhythmia. Int J Mol Sci 2020;22:E188. [PMID: 33375447 DOI: 10.3390/ijms22010188] [Reference Citation Analysis]
216 Klau J, Bernardo CO, Gonzalez-Chica DA, Raven M, Jureidini J. Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018. Aust N Z J Psychiatry 2021;:48674211067720. [PMID: 34963342 DOI: 10.1177/00048674211067720] [Reference Citation Analysis]
217 Whitehorne-Smith P, Burns S, Milbourn B, Abel W, Martin R. Cross-sectional mixed-methods study protocol exploring the enablers and barriers for people with severe and enduring mental illness in Jamaica when accessing healthcare for chronic physical illness. BMJ Open 2020;10:e038245. [PMID: 32753453 DOI: 10.1136/bmjopen-2020-038245] [Reference Citation Analysis]
218 Kenanidis E, Zagalioti SC, Milonakis N, Tsapakis EM, Tsiridis E. A Catastrophic Cascade of Postoperative Complications Following Hemiarthroplasty for Femoral Neck Fracture in a Middle-Aged Patient With Schizophrenia. Cureus 2020;12:e9044. [PMID: 32782863 DOI: 10.7759/cureus.9044] [Reference Citation Analysis]
219 Søgaard M, Skjøth F, Kjældgaard JN, Larsen TB, Hjortshøj SP, Riahi S. Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study. BMJ Open 2017;7:e018209. [PMID: 29217725 DOI: 10.1136/bmjopen-2017-018209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
220 Akkouh IA, Hughes T, Steen VM, Glover JC, Andreassen OA, Djurovic S, Szabo A. Transcriptome analysis reveals disparate expression of inflammation-related miRNAs and their gene targets in iPSC-astrocytes from people with schizophrenia. Brain Behav Immun 2021;94:235-44. [PMID: 33571628 DOI: 10.1016/j.bbi.2021.01.037] [Reference Citation Analysis]
221 Tovilla-Zárate CA, Pérez-Mandujano A, Ramírez-González IR, Fresan A, Suarez-Mendez S, Martínez-Villaseñor E, Rodríguez-Sánchez E, Villar-Soto M, López-Narváez ML, González-Castro TB, Ble-Castillo JL, Juárez-Rojop IE. Vortioxetine versus sertraline in metabolic control, distress and depression in Mexican patients with type 2 diabetes. Ann Transl Med 2019;7:656. [PMID: 31930057 DOI: 10.21037/atm.2019.10.56] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
222 Schneider-Thoma J, Efthimiou O, Bighelli I, Dörries C, Huhn M, Krause M, Reichelt L, Röder H, Furukawa TA, Davis JM, Leucht S. Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis. Lancet Psychiatry 2019;6:753-65. [PMID: 31320283 DOI: 10.1016/S2215-0366(19)30223-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
223 Gupta S, Lakshmanan DAM, Khastgir U, Nair R. Management of antipsychotic-induced hyperprolactinaemia. BJPsych advances 2017;23:278-86. [DOI: 10.1192/apt.bp.115.014928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
224 Rask Larsen J, Dima L, Correll CU, Manu P. The pharmacological management of metabolic syndrome. Expert Rev Clin Pharmacol. 2018;11:397-410. [PMID: 29345505 DOI: 10.1080/17512433.2018.1429910] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
225 Davis RE, Correll CU. ITI-007 in the treatment of schizophrenia: from novel pharmacology to clinical outcomes. Expert Rev Neurother. 2016;16:601-614. [PMID: 27042868 DOI: 10.1080/14737175.2016.1174577] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
226 Ma Q, Yang F, Ma B, Jing W, Liu J, Guo M, Li J, Wang Z, Liu M. Risk of dyslipidaemia with antipsychotic drug treatment in Chinese inpatients with mental illness: a hospital-based cohort study. BMJ Open 2021;11:e043259. [PMID: 33518524 DOI: 10.1136/bmjopen-2020-043259] [Reference Citation Analysis]
227 Martens N, Destoop M, Dom G. Organization of Community Mental Health Services for Persons with a Severe Mental Illness and Comorbid Somatic Conditions: A Systematic Review on Somatic Outcomes and Health Related Quality of Life. Int J Environ Res Public Health 2021;18:E462. [PMID: 33435525 DOI: 10.3390/ijerph18020462] [Reference Citation Analysis]
228 Kahl KG. Direct and indirect effects of psychopharmacological treatment on the cardiovascular system. Horm Mol Biol Clin Investig 2018;36. [PMID: 30427780 DOI: 10.1515/hmbci-2018-0054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
229 Cussotto S, Strain CR, Fouhy F, Strain RG, Peterson VL, Clarke G, Stanton C, Dinan TG, Cryan JF. Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology 2019;236:1671-85. [DOI: 10.1007/s00213-018-5006-5] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 17.8] [Reference Citation Analysis]
230 Wu Y, Zhu B, Chen Z, Duan J, Luo A, Yang L, Yang C. Prevalence and predisposing factors of depressive symptoms in patients with stable coronary artery disease: a cross-sectional single-center study. Aging (Albany NY) 2019;11:3958-68. [PMID: 31205006 DOI: 10.18632/aging.102026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
231 Correll CU, Rubio JM, Kane JM. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? World Psychiatry 2018;17:149-60. [PMID: 29856543 DOI: 10.1002/wps.20516] [Cited by in Crossref: 91] [Cited by in F6Publishing: 69] [Article Influence: 22.8] [Reference Citation Analysis]
232 Maripuu M, Bendix M, Öhlund L, Widerström M, Werneke U. Death Associated With Coronavirus (COVID-19) Infection in Individuals With Severe Mental Disorders in Sweden During the Early Months of the Outbreak-An Exploratory Cross-Sectional Analysis of a Population-Based Register Study. Front Psychiatry 2020;11:609579. [PMID: 33488430 DOI: 10.3389/fpsyt.2020.609579] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
233 Watkins LR, Orlandi C. Orphan G Protein Coupled Receptors in Affective Disorders. Genes (Basel) 2020;11:E694. [PMID: 32599826 DOI: 10.3390/genes11060694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
234 Liang Y, Yang M, Zhao G, Mao Y, Zhang L, Hu Z. Relationship between mortality in people with mental disorders and suicide mortality in China during 2000 to 2014: An observational study. Medicine (Baltimore) 2018;97:e13359. [PMID: 30544403 DOI: 10.1097/MD.0000000000013359] [Reference Citation Analysis]
235 Stapel B, Kotsiari A, Scherr M, Hilfiker-kleiner D, Bleich S, Frieling H, Kahl KG. Olanzapine and aripiprazole differentially affect glucose uptake and energy metabolism in human mononuclear blood cells. Journal of Psychiatric Research 2017;88:18-27. [DOI: 10.1016/j.jpsychires.2016.12.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
236 Birkenæs V, Elvsåshagen T, Westlye LT, Høegh MC, Haram M, Werner MCF, Quintana DS, Lunding SH, Martin-Ruiz C, Agartz I, Djurovic S, Steen NE, Andreassen OA, Aas M. Telomeres are shorter and associated with number of suicide attempts in affective disorders. J Affect Disord 2021;295:1032-9. [PMID: 34706411 DOI: 10.1016/j.jad.2021.08.135] [Reference Citation Analysis]
237 Agaba DC, Migisha R, Namayanja R, Katamba G, Lugobe HM, Aheisibwe H, Twesigomwe G, Ashaba S. Prevalence and Associated Factors of Metabolic Syndrome among Patients with Severe Mental Illness Attending a Tertiary Hospital in Southwest Uganda. Biomed Res Int 2019;2019:1096201. [PMID: 31815121 DOI: 10.1155/2019/1096201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
238 Kane JM, Durgam S, Satlin A, Vanover KE, Chen R, Davis R, Mates S. Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials. Int Clin Psychopharmacol 2021;36:244-50. [PMID: 34054112 DOI: 10.1097/YIC.0000000000000371] [Reference Citation Analysis]
239 Sampaio-Junior B, Tortella G, Borrione L, Moffa AH, Machado-Vieira R, Cretaz E, Fernandes da Silva A, Fraguas R, Aparício LV, Klein I, Lafer B, Goerigk S, Benseñor IM, Lotufo PA, Gattaz WF, Brunoni AR. Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial. JAMA Psychiatry 2018;75:158-66. [PMID: 29282470 DOI: 10.1001/jamapsychiatry.2017.4040] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 19.7] [Reference Citation Analysis]
240 Abou Kassm S, Hoertel N, Naja W, Mcmahon K, Barrière S, Blumenstock Y, Portefaix C, Raucher-chéné D, Béra-potelle C, Cuervo-lombard C, Guerin-langlois C, Lemogne C, Peyre H, Kaladjian A, Limosin F. Metabolic syndrome among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study. Psychiatry Research 2019;275:238-46. [DOI: 10.1016/j.psychres.2019.03.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
241 Kahl KG, Stapel B, Frieling H. Link between depression and cardiovascular diseases due to epigenomics and proteomics: Focus on energy metabolism. Prog Neuropsychopharmacol Biol Psychiatry 2019;89:146-57. [PMID: 30194950 DOI: 10.1016/j.pnpbp.2018.09.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
242 Baldessarini RJ, Vázquez GH, Tondo L. Bipolar depression: a major unsolved challenge. Int J Bipolar Disord 2020;8:1. [PMID: 31903509 DOI: 10.1186/s40345-019-0160-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
243 Mulder R, Hamilton A, Irwin L, Boyce P, Morris G, Porter RJ, Malhi GS. Treating depression with adjunctive antipsychotics. Bipolar Disord 2018;20:17-24. [DOI: 10.1111/bdi.12701] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
244 Qriouet Z, Cherrah Y, Sefrioui H, Qmichou Z. Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection. Molecules 2021;26:1058. [PMID: 33670468 DOI: 10.3390/molecules26041058] [Reference Citation Analysis]
245 Ayyagari R, Thomason D, Mu F, Philbin M, Carroll B. Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders. J Med Econ 2020;23:204-12. [PMID: 31663802 DOI: 10.1080/13696998.2019.1685818] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
246 Williams J, Fairbairn E, McGrath R, Bakolis I, Healey A, Akpan U, Mdudu I, Gaughran F, Sadler E, Khadjesari Z, Lillywhite K, Sevdalis N. A feasibility hybrid II randomised controlled trial of volunteer 'Health Champions' supporting people with serious mental illness manage their physical health: study protocol. Pilot Feasibility Stud 2021;7:116. [PMID: 34059148 DOI: 10.1186/s40814-021-00854-8] [Reference Citation Analysis]
247 Vancampfort D, Hagemann N, Wyckaert S, Rosenbaum S, Stubbs B, Firth J, Schuch FB, Probst M, Sienaert P. Higher cardio-respiratory fitness is associated with increased mental and physical quality of life in people with bipolar disorder: A controlled pilot study. Psychiatry Research 2017;256:219-24. [DOI: 10.1016/j.psychres.2017.06.066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
248 Mcelroy SL, Guerdjikova AI, Mori N, Keck PE. Managing comorbid obesity and depression through clinical pharmacotherapies. Expert Opinion on Pharmacotherapy 2016;17:1599-610. [DOI: 10.1080/14656566.2016.1198776] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
249 Athanasopoulou C, Välimäki M, Koutra K, Löttyniemi E, Bertsias A, Basta M, Vgontzas AN, Lionis C. Internet use, eHealth literacy and attitudes toward computer/internet among people with schizophrenia spectrum disorders: a cross-sectional study in two distant European regions. BMC Med Inform Decis Mak 2017;17:136. [PMID: 28931385 DOI: 10.1186/s12911-017-0531-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
250 De Hert M, Peuskens J, Sabbe T, Mitchell AJ, Stubbs B, Neven P, Wildiers H, Detraux J. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatr Scand 2016;133:5-22. [DOI: 10.1111/acps.12459] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
251 Jazi S, Ben-Amor L, Abadie P, Menard ML, Choquette R, Berthiaume C, Mottron L, Ilies D. Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Métabolique à Long Terme des Jeunes Traités par Antipsychotiques de Deuxième Génération, Cinq ans Après la publication des Lignes Directrices Camesa: Faisons-Nous des Progrès? Can J Psychiatry 2021;66:645-56. [PMID: 33243011 DOI: 10.1177/0706743720974847] [Reference Citation Analysis]
252 De Hert M, Detraux J, Stubbs B. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review. Expert Opin Drug Saf 2016;15:809-23. [PMID: 26986209 DOI: 10.1517/14740338.2016.1167873] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
253 Fusar-poli L, Surace T, Vanella A, Meo V, Patania F, Furnari R, Signorelli MS, Aguglia E. The effect of adjunctive nutraceuticals in bipolar disorder: A systematic review of randomized placebo-controlled trials. Journal of Affective Disorders 2019;252:334-49. [DOI: 10.1016/j.jad.2019.04.039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
254 Delacrétaz A, Vandenberghe F, Glatard A, Levier A, Dubath C, Ansermot N, Crettol S, Gholam-Rezaee M, Guessous I, Bochud M, von Gunten A, Conus P, Eap CB. Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances. Front Psychiatry 2018;9:573. [PMID: 30473668 DOI: 10.3389/fpsyt.2018.00573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
255 Higgs S, Spetter MS, Thomas JM, Rotshtein P, Lee M, Hallschmid M, Dourish CT. Interactions between metabolic, reward and cognitive processes in appetite control: Implications for novel weight management therapies. J Psychopharmacol 2017;31:1460-74. [PMID: 29072515 DOI: 10.1177/0269881117736917] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
256 Lyall LM, Penades N, Smith DJ. Changes in prescribing for bipolar disorder between 2009 and 2016: national-level data linkage study in Scotland. Br J Psychiatry 2019;215:415-21. [PMID: 30816839 DOI: 10.1192/bjp.2019.16] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
257 Ge W, Li H, Zhao Y, Cai E, Zhu H, Gao Y, Liu S, Yang H, Zhang L. Study on antidepressant activity of sesquiterpenoids from ginseng root. Journal of Functional Foods 2017;33:261-7. [DOI: 10.1016/j.jff.2017.03.057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
258 Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC Med 2020;18:215. [PMID: 32664944 DOI: 10.1186/s12916-020-01685-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
259 Eskelinen S, Suvisaari JVJ, Suvisaari JM. Physical health examination in outpatients with schizophrenia: the cost effectiveness of laboratory screening tests. Ann Gen Psychiatry 2020;19:70. [PMID: 33308252 DOI: 10.1186/s12991-020-00321-3] [Reference Citation Analysis]
260 Svensson CK, Larsen JR, Vedtofte L, Jakobsen MSL, Jespersen HR, Jakobsen MI, Koyuncu K, Schjerning O, Nielsen J, Ekstrøm CT, Correll CU, Vilsbøll T, Fink-jensen A. One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients. Acta Psychiatr Scand 2019;139:26-36. [DOI: 10.1111/acps.12982] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
261 Fabrazzo M, Fuschillo A, Perris F, Catapano F. The unmasking of hidden severe hyponatremia after long-term combination therapy in exacerbated bipolar patients: a case series. Int Clin Psychopharmacol 2019;34:206-10. [PMID: 30998596 DOI: 10.1097/YIC.0000000000000265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
262 Hempler NF, Pals RAS, Pedersbæk L, DeCosta P. Barriers and facilitators of effective health education targeting people with mental illness: a theory-based ethnographic study. BMC Psychiatry 2018;18:353. [PMID: 30376824 DOI: 10.1186/s12888-018-1924-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
263 Amare AT, Schubert KO, Klingler-Hoffmann M, Cohen-Woods S, Baune BT. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Transl Psychiatry 2017;7:e1007. [PMID: 28117839 DOI: 10.1038/tp.2016.261] [Cited by in Crossref: 126] [Cited by in F6Publishing: 110] [Article Influence: 25.2] [Reference Citation Analysis]
264 Zhang B, Chang HS, Hu KL, Yu X, Li LN, Xu XQ. Combination of Geniposide and Eleutheroside B Exerts Antidepressant-like Effect on Lipopolysaccharide-Induced Depression Mice Model. Chin J Integr Med 2021;27:534-41. [PMID: 31784933 DOI: 10.1007/s11655-019-3051-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
265 De Hert M, Detraux J, Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin Neurosci 2018;20:31-40. [PMID: 29946209 [PMID: 29946209 DOI: 10.31887/dcns.2018.20.1/mdehert] [Cited by in Crossref: 101] [Article Influence: 25.3] [Reference Citation Analysis]
266 Blomqvist M, Ivarsson A, Carlsson IM, Sandgren A, Jormfeldt H. Health Risks among People with Severe Mental Illness in Psychiatric Outpatient Settings. Issues Ment Health Nurs 2018;39:585-91. [PMID: 29446657 DOI: 10.1080/01612840.2017.1422200] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
267 De Rosa C, Sampogna G, Luciano M, Del Vecchio V, Pocai B, Borriello G, Giallonardo V, Savorani M, Pinna F, Pompili M, Fiorillo A. Improving physical health of patients with severe mental disorders: a critical review of lifestyle psychosocial interventions. Expert Rev Neurother 2017;17:667-81. [PMID: 28468528 DOI: 10.1080/14737175.2017.1325321] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
268 Zhang JP, Lencz T, Zhang RX, Nitta M, Maayan L, John M, Robinson DG, Fleischhacker WW, Kahn RS, Ophoff RA, Kane JM, Malhotra AK, Correll CU. Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis. Schizophr Bull 2016;42:1418-37. [PMID: 27217270 DOI: 10.1093/schbul/sbw058] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 14.5] [Reference Citation Analysis]
269 Goldstein BI, Korczak DJ. Links Between Child and Adolescent Psychiatric Disorders and Cardiovascular Risk. Canadian Journal of Cardiology 2020;36:1394-405. [DOI: 10.1016/j.cjca.2020.06.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
270 Stanton R. Integration of the Exercise Professional Within the Mental Health Multidisciplinary Team. Exercise-Based Interventions for Mental Illness. Elsevier; 2018. pp. 243-63. [DOI: 10.1016/b978-0-12-812605-9.00013-7] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
271 Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, Rosenbaum S, Correll CU. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14:339-347. [PMID: 26407790 DOI: 10.1002/wps.20252] [Cited by in Crossref: 532] [Cited by in F6Publishing: 479] [Article Influence: 76.0] [Reference Citation Analysis]
272 Hassan S, Ross J, Marston L, Osborn D, Walters K. Factors prospectively associated with physical activity and dietary related outcomes in people with severe mental illness: A systematic review of longitudinal studies. Psychiatry Res 2019;273:181-91. [PMID: 30654303 DOI: 10.1016/j.psychres.2018.12.115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
273 Khouzam HR. Identification and management of tardive dyskinesia: A case series and literature review. Postgrad Med 2015;127:726-37. [PMID: 26216578 DOI: 10.1080/00325481.2015.1074031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
274 Virtanen T, Eskelinen S, Sailas E, Suvisaari J. Dyspepsia and constipation in patients with schizophrenia spectrum disorders. Nordic Journal of Psychiatry 2016;71:48-54. [DOI: 10.1080/08039488.2016.1217044] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
275 Pisano S, Catone G, Veltri S, Lanzara V, Pozzi M, Clementi E, Iuliano R, Riccio MP, Radice S, Molteni M, Capuano A, Gritti A, Coppola G, Milone A, Bravaccio C, Masi G. Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists. Ital J Pediatr 2016;42:51. [PMID: 27209326 DOI: 10.1186/s13052-016-0259-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
276 Dorney K, Murphy M. Recommendations for the medical work-up of first episode psychosis, including specific relevance to Indigenous Australians: A narrative review. Early Interv Psychiatry 2021;15:423-38. [PMID: 32543124 DOI: 10.1111/eip.12980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
277 Whitaker R. Viewpoint: do antipsychotics protect against early death? A critical view. Psychol Med 2020;50:2643-52. [PMID: 33050955 DOI: 10.1017/S003329172000358X] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
278 Kirschner V, Lamp N, Dinc Ü, Becker T, Kilian R, Mueller-Stierlin AS. The evaluation of a physical health promotion intervention for people with severe mental illness receiving community based accommodational support: a mixed-method pilot study. BMC Psychiatry 2022;22:6. [PMID: 34983452 DOI: 10.1186/s12888-021-03640-1] [Reference Citation Analysis]
279 Harrison PJ, Cipriani A, Harmer CJ, Nobre AC, Saunders K, Goodwin GM, Geddes JR. Innovative approaches to bipolar disorder and its treatment. Ann N Y Acad Sci 2016;1366:76-89. [PMID: 27111134 DOI: 10.1111/nyas.13048] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
280 Taipale H, Tanskanen A, Mehtälä J, Vattulainen P, Correll CU, Tiihonen J. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry 2020;19:61-8. [PMID: 31922669 DOI: 10.1002/wps.20699] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 30.5] [Reference Citation Analysis]
281 Korkut Celikates B, Kilic V, Atli-Eklioglu O, Baysal M, Aydogan-Kılıc G, Ucarcan S, Ilgin S. Effects of quetiapine administration on sperm quality and testicular histology. Drug Chem Toxicol 2021;:1-9. [PMID: 34229556 DOI: 10.1080/01480545.2021.1946558] [Reference Citation Analysis]
282 Speyer H, Christian Brix Nørgaard H, Birk M, Karlsen M, Storch Jakobsen A, Pedersen K, Hjorthøj C, Pisinger C, Gluud C, Mors O, Krogh J, Nordentoft M. The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity. World Psychiatry 2016;15:155-65. [PMID: 27265706 DOI: 10.1002/wps.20318] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 13.8] [Reference Citation Analysis]
283 Anyanwagu U, Idris I, Donnelly R. Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism. Clin Pharmacol Ther 2016;99:390-400. [PMID: 26440603 DOI: 10.1002/cpt.274] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
284 Butler J, de Cassan S, Glogowska M, Fanshawe TR, Turner P, Walton D, Lasserson D, Bale R, Lennox B, Hayward G. Effect of point of care blood testing on physical health check completion in mental health services: mixed-methods evaluation. BJPsych Open 2020;6:e127. [PMID: 33107428 DOI: 10.1192/bjo.2020.110] [Reference Citation Analysis]
285 Singh SP, Mohan M, Giacco D. Psychosocial interventions for people with a first episode psychosis: between tradition and innovation. Curr Opin Psychiatry 2021;34:460-6. [PMID: 34282104 DOI: 10.1097/YCO.0000000000000726] [Reference Citation Analysis]
286 Correll CU, Davis RE, Weingart M, Saillard J, O'Gorman C, Kane JM, Lieberman JA, Tamminga CA, Mates S, Vanover KE. Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial. JAMA Psychiatry 2020;77:349-58. [PMID: 31913424 DOI: 10.1001/jamapsychiatry.2019.4379] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 21.0] [Reference Citation Analysis]
287 Horska K, Kotolova H, Karpisek M, Babinska Z, Hammer T, Prochazka J, Stark T, Micale V, Ruda-Kucerova J. Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation. Toxicol Appl Pharmacol 2020;406:115214. [PMID: 32866524 DOI: 10.1016/j.taap.2020.115214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
288 Tomizawa Y, Kurokawa S, Ishii D, Miyaho K, Ishii C, Sanada K, Fukuda S, Mimura M, Kishimoto T. Effects of Psychotropics on the Microbiome in Patients With Depression and Anxiety: Considerations in a Naturalistic Clinical Setting. Int J Neuropsychopharmacol 2021;24:97-107. [PMID: 32975292 DOI: 10.1093/ijnp/pyaa070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
289 Lenze EJ, Ramsey A, Brown PJ, Reynolds CF 3rd, Mulsant BH, Lavretsky H, Roose SP. Older Adults' Perspectives on Clinical Research: A Focus Group and Survey Study. Am J Geriatr Psychiatry 2016;24:893-902. [PMID: 27591916 DOI: 10.1016/j.jagp.2016.07.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
290 de Hert M, Detraux J. Reversing the downward spiral for people with severe mental illness through educational innovations. World Psychiatry 2017;16:41-2. [PMID: 28127924 DOI: 10.1002/wps.20377] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
291 Miola A, Pinna M, Manchia M, Tondo L, Baldessarini RJ. Overweight in mood disorders: Effects on morbidity and treatment response. J Affect Disord 2021;297:169-75. [PMID: 34699849 DOI: 10.1016/j.jad.2021.10.032] [Reference Citation Analysis]
292 Pruett BS, Meador-Woodruff JH. Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies. Schizophr Res 2020;223:29-42. [PMID: 32958361 DOI: 10.1016/j.schres.2020.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
293 Sebastianski M, Gates M, Gates A, Nuspl M, Bialy LM, Featherstone RM, Breault L, Mason-Lai P, Hartling L. Evidence available for patient-identified priorities in depression research: results of 11 rapid responses. BMJ Open 2019;9:e026847. [PMID: 31256024 DOI: 10.1136/bmjopen-2018-026847] [Reference Citation Analysis]
294 Vancampfort D, Stubbs B. Physical activity and metabolic disease among people with affective disorders: Prevention, management and implementation. J Affect Disord 2017;224:87-94. [PMID: 27519365 DOI: 10.1016/j.jad.2016.07.042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
295 Xu M, Guo S, Yang F, Wang Y, Wu C, Jiang X, Zhao Q, Chen W, Tian G, Zhu F, Xie Y, Hu T, Wang Z, He Y, Shen J. Continuation of structure–activity relationship study of novel benzamide derivatives as potential antipsychotics. Arch Pharm Chem Life Sci 2019;352:1800306. [DOI: 10.1002/ardp.201800306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
296 Nestsiarovich A, Kerner B, Mazurie AJ, Cannon DC, Hurwitz NG, Zhu Y, Nelson SJ, Oprea TI, Crisanti AS, Tohen M, Perkins DJ, Lambert CG. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder. Psychoneuroendocrinology 2020;112:104511. [DOI: 10.1016/j.psyneuen.2019.104511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
297 Wong-Anuchit C, Chantamit-O-Pas C, Schneider JK, Mills AC. Motivational Interviewing-Based Compliance/Adherence Therapy Interventions to Improve Psychiatric Symptoms of People With Severe Mental Illness: Meta-Analysis. J Am Psychiatr Nurses Assoc 2019;25:122-33. [PMID: 29504450 DOI: 10.1177/1078390318761790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
298 Scheewe TW, Jörg F, Takken T, Deenik J, Vancampfort D, Backx FJG, Cahn W. Low Physical Activity and Cardiorespiratory Fitness in People With Schizophrenia: A Comparison With Matched Healthy Controls and Associations With Mental and Physical Health. Front Psychiatry 2019;10:87. [PMID: 30873051 DOI: 10.3389/fpsyt.2019.00087] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
299 Sušilová L, Češková E, Hampel D, Sušil A, Šimůnek J. Changes in BMI in hospitalized patients during treatment with antipsychotics, depending on gender and other factors. International Journal of Psychiatry in Clinical Practice 2017;21:112-7. [DOI: 10.1080/13651501.2017.1291818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
300 Wang CH, Lee TY, Hui KC, Chung MH. Mental disorders and medical comorbidities: Association rule mining approach. Perspect Psychiatr Care 2019;55:517-26. [PMID: 30734309 DOI: 10.1111/ppc.12362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
301 de Caluwé L, van Buitenen N, Gelan PJ, Crunelle CL, Thomas R, Casseres S, Matthys F, van Harten P, Cahn W. Prevalence of metabolic syndrome and its associated risk factors in an African-Caribbean population with severe mental illness. Psychiatry Res 2019;281:112558. [PMID: 31546147 DOI: 10.1016/j.psychres.2019.112558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
302 Li Z, Chen P, Chen J, Xu Y, Wang Q, Li X, Li C, He L, Shi Y. Glucose and Insulin-Related Traits, Type 2 Diabetes and Risk of Schizophrenia: A Mendelian Randomization Study. EBioMedicine 2018;34:182-8. [PMID: 30100396 DOI: 10.1016/j.ebiom.2018.07.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
303 Chen P, Tsai S, Pan C, Chang C, Su S, Chen C, Kuo C. Age effect of antipsychotic medications on the risk of sudden cardiac death in patients with schizophrenia: A nationwide case–crossover study. Psychiatry Clin Neurosci 2020;74:594-601. [DOI: 10.1111/pcn.13116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
304 Suggett J, Foster K, Lakra V, Steele M, Furness T. Natural cause mortality of mental health consumers: A 10-year retrospective cohort study. Int J Ment Health Nurs 2021;30:390-400. [PMID: 33035405 DOI: 10.1111/inm.12797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
305 Li X, Deng W, Xue R, Wang Q, Ren H, Wei W, Zhang Y, Li M, Zhao L, Du X, Meng Y, Ma X, Hall MH, Li T. Auditory event-related potentials, neurocognition, and global functioning in drug naïve first-episode schizophrenia and bipolar disorder. Psychol Med 2021;:1-10. [PMID: 34474699 DOI: 10.1017/S0033291721002130] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Forero JP, Ferrera A, Castaño JD, Ardila S, Mesa T, Hosgood D, Ferro E. Bipolar Disorder and Cardiovascular Risk in Rural versus Urban Populations in Colombia: A Comparative Clinical and Epidemiological Evaluation. Ann Glob Health 2021;87:112. [PMID: 34824993 DOI: 10.5334/aogh.3479] [Reference Citation Analysis]
307 Deest M, Jakob MM, Seifert J, Bleich S, Frieling H, Eberlein C. Sertraline as a treatment option for temper outbursts in Prader-Willi syndrome. Am J Med Genet A 2021;185:790-7. [PMID: 33369086 DOI: 10.1002/ajmg.a.62041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
308 Clouston SAP, Jonas K, Fochtmann LJ, Bromet EJ, Kotov R. Physical Functional Limitations in a First-Admission Cohort at Midlife: Findings From the Suffolk County Mental Health Project. J Gerontol A Biol Sci Med Sci 2020;75:1424-30. [PMID: 31566202 DOI: 10.1093/gerona/glz227] [Reference Citation Analysis]
309 Maj M, van Os J, De Hert M, Gaebel W, Galderisi S, Green MF, Guloksuz S, Harvey PD, Jones PB, Malaspina D, McGorry P, Miettunen J, Murray RM, Nuechterlein KH, Peralta V, Thornicroft G, van Winkel R, Ventura J. The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry 2021;20:4-33. [PMID: 33432763 DOI: 10.1002/wps.20809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
310 Weissinger GM, Carthon JMB, Brawner BM. Non-psychiatric hospitalization length-of-stay for patients with psychotic disorders: A mixed methods study. Gen Hosp Psychiatry 2020;67:1-9. [PMID: 32866772 DOI: 10.1016/j.genhosppsych.2020.07.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
311 Scott EM, Carpenter JS, Iorfino F, Cross SPM, Hermens DF, Gehue J, Wilson C, White D, Naismith SL, Guastella AJ, Hickie IB. What is the prevalence, and what are the clinical correlates, of insulin resistance in young people presenting for mental health care? A cross-sectional study. BMJ Open 2019;9:e025674. [PMID: 31138580 DOI: 10.1136/bmjopen-2018-025674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
312 Mannapperuma U, Galappatthy P, Jayakody RL, Mendis J, de Silva VA, Hanwella R. Safety monitoring of treatment in bipolar disorder in a tertiary care setting in Sri Lanka and recommendations for improved monitoring in resource limited settings. BMC Psychiatry 2019;19:194. [PMID: 31234824 DOI: 10.1186/s12888-019-2183-7] [Reference Citation Analysis]
313 Danial M, Hassali MA, Meng OL, Kin YC, Khan AH. Development of a mortality score to assess risk of adverse drug reactions among hospitalized patients with moderate to severe chronic kidney disease. BMC Pharmacol Toxicol. 2019;20:41. [PMID: 31287030 DOI: 10.1186/s40360-019-0318-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
314 Eskelinen S, Sailas E, Joutsenniemi K, Holi M, Koskela TH, Suvisaari J. Multiple physical healthcare needs among outpatients with schizophrenia: findings from a health examination study. Nord J Psychiatry 2017;71:448-54. [PMID: 28497707 DOI: 10.1080/08039488.2017.1319497] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
315 Sutterland AL, Blom MT, Ladee K, Lubbers JJM, Cohen D, de Haan L, Tan HL. Increased prevalence of ECG suspicious for Brugada Syndrome in recent onset schizophrenia spectrum disorders. Schizophr Res 2019;210:59-65. [PMID: 31248748 DOI: 10.1016/j.schres.2019.06.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
316 Fernandes TMP, Andrade SM, de Andrade MJO, Nogueira RMTBL, Santos NA. Colour discrimination thresholds in type 1 Bipolar Disorder: a pilot study. Sci Rep 2017;7:16405. [PMID: 29180712 DOI: 10.1038/s41598-017-16752-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
317 McGowan NM, Nichols M, Bilderbeck AC, Goodwin GM, Saunders KEA. Blood pressure in bipolar disorder: evidence of elevated pulse pressure and associations between mean pressure and mood instability. Int J Bipolar Disord 2021;9:5. [PMID: 33521889 DOI: 10.1186/s40345-020-00209-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
318 Caroff SN, Mu F, Ayyagari R, Schilling T, Abler V, Carroll B. Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia. BMC Psychiatry 2020;20:365. [PMID: 32652964 DOI: 10.1186/s12888-020-02748-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
319 Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, Thapa-Chhetri N, Fornaro M, Gallicchio D, Collantoni E, Pigato G, Favaro A, Monaco F, Kohler C, Vancampfort D, Ward PB, Gaughran F, Carvalho AF, Stubbs B. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 2017;16:163-80. [PMID: 28498599 DOI: 10.1002/wps.20420] [Cited by in Crossref: 531] [Cited by in F6Publishing: 486] [Article Influence: 106.2] [Reference Citation Analysis]
320 Yang C, Zhong X, Zhou H, Wu Z, Zhang M, Ning Y. Physical Comorbidities are Independently Associated with Higher Rates of Psychiatric Readmission in a Chinese Han Population. Neuropsychiatr Dis Treat 2020;16:2073-82. [PMID: 32982246 DOI: 10.2147/NDT.S261223] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
321 Finkelstein Y, Macdonald EM, Li P, Mamdani MM, Gomes T, Juurlink DN. Second-generation anti-depressants and risk of new-onset seizures in the elderly. Clin Toxicol (Phila) 2018;56:1179-84. [PMID: 29989445 DOI: 10.1080/15563650.2018.1483025] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
322 Yang F, Ma Q, Ma B, Jing W, Liu J, Guo M, Li J, Wang Z, Liu M. Dyslipidemia prevalence and trends among adult mental disorder inpatients in Beijing, 2005-2018: A longitudinal observational study. Asian J Psychiatr 2021;57:102583. [PMID: 33581368 DOI: 10.1016/j.ajp.2021.102583] [Reference Citation Analysis]
323 Chen P, Tsai S, Pan C, Chang C, Su S, Chen C, Kuo C. Mood stabilisers and risk of stroke in bipolar disorder. Br J Psychiatry 2019;215:409-14. [DOI: 10.1192/bjp.2018.203] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
324 Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, Rosenbaum S, Gaughran F, Lally J, Stubbs B. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry 2016;15:166-74. [PMID: 27265707 DOI: 10.1002/wps.20309] [Cited by in Crossref: 301] [Cited by in F6Publishing: 287] [Article Influence: 50.2] [Reference Citation Analysis]
325 Simoons M, Mulder H, Doornbos B, Schoevers RA, van Roon EN, Ruhé HG. Monitoring of somatic parameters at outpatient departments for mood and anxiety disorders. PLoS One 2018;13:e0200520. [PMID: 30130372 DOI: 10.1371/journal.pone.0200520] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
326 Gronholm PC, Chowdhary N, Barbui C, Das-Munshi J, Kolappa K, Thornicroft G, Semrau M, Dua T. Prevention and management of physical health conditions in adults with severe mental disorders: WHO recommendations. Int J Ment Health Syst 2021;15:22. [PMID: 33658061 DOI: 10.1186/s13033-021-00444-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
327 de Beaurepaire R. Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia: Prevalence, Antipsychotic Specificities, and Changes Over Time. J Clin Psychopharmacol 2021;41:114-20. [PMID: 33587392 DOI: 10.1097/JCP.0000000000001357] [Reference Citation Analysis]
328 Eriksson R, Broberg BV, Ishøy PL, Bak N, Andersen UB, Jørgensen NR, Knop FK, Ebdrup BH. Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density. Front Psychiatry 2018;9:781. [PMID: 30745885 DOI: 10.3389/fpsyt.2018.00781] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
329 Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, Druss B, Dudek K, Freeman M, Fujii C, Gaebel W, Hegerl U, Levav I, Munk Laursen T, Ma H, Maj M, Elena Medina-Mora M, Nordentoft M, Prabhakaran D, Pratt K, Prince M, Rangaswamy T, Shiers D, Susser E, Thornicroft G, Wahlbeck K, Fekadu Wassie A, Whiteford H, Saxena S. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry 2017;16:30-40. [PMID: 28127922 DOI: 10.1002/wps.20384] [Cited by in Crossref: 244] [Cited by in F6Publishing: 211] [Article Influence: 48.8] [Reference Citation Analysis]
330 Vancampfort D, Firth J, Correll CU, Solmi M, Siskind D, De Hert M, Carney R, Koyanagi A, Carvalho AF, Gaughran F, Stubbs B. The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 2019;18:53-66. [PMID: 30600626 DOI: 10.1002/wps.20614] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 21.0] [Reference Citation Analysis]
331 Stogios N, Smith E, Bowden S, Tran V, Asgariroozbehani R, McIntyre WB, Remington G, Siskind D, Agarwal SM, Hahn MK. Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis. Neuropsychopharmacology 2021. [PMID: 34446830 DOI: 10.1038/s41386-021-01163-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
332 Borrione L, Moffa AH, Martin D, Loo CK, Brunoni AR. Transcranial Direct Current Stimulation in the Acute Depressive Episode: A Systematic Review of Current Knowledge. J ECT 2018;34:153-63. [DOI: 10.1097/yct.0000000000000512] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 5.8] [Reference Citation Analysis]
333 Martínez-Alés G, López-Cuadrado T, Olfson M, Bouza C. Use and outcomes of mechanical ventilation for people with severe mental disorders admitted due to natural causes: A nationwide population-based study. Gen Hosp Psychiatry 2020;65:15-20. [PMID: 32361660 DOI: 10.1016/j.genhosppsych.2020.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
334 Maurus I, Hasan A, Röh A, Takahashi S, Rauchmann B, Keeser D, Malchow B, Schmitt A, Falkai P. Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2019;269:499-515. [PMID: 31115660 DOI: 10.1007/s00406-019-01025-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
335 Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW. Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2019;73:1827-45. [PMID: 30975301 DOI: 10.1016/j.jacc.2019.01.041] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 23.0] [Reference Citation Analysis]
336 Minhas S, Patel JR, Malik M, Hana D, Hassan F, Khouzam RN. Mind-Body Connection: Cardiovascular Sequelae of Psychiatric Illness. Curr Probl Cardiol 2021;:100959. [PMID: 34358587 DOI: 10.1016/j.cpcardiol.2021.100959] [Reference Citation Analysis]
337 Broderick J, Crumlish N, Waugh A, Vancampfort D. Yoga versus non-standard care for schizophrenia. Cochrane Database Syst Rev 2017;9:CD012052. [PMID: 28956893 DOI: 10.1002/14651858.CD012052.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
338 Barnes TRE, MacCabe JH, Kane JM, Delgado O, Paton C. The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services. Ther Adv Psychopharmacol 2020;10:2045125320937908. [PMID: 32821377 DOI: 10.1177/2045125320937908] [Reference Citation Analysis]
339 Rong J, Chen G, Wang X, Ge Y, Meng N, Xie T, Ding H. Correlation Between Depressive Symptoms And Quality Of Life, And Associated Factors For Depressive Symptoms Among Rural Elderly In Anhui, China. Clin Interv Aging 2019;14:1901-10. [PMID: 31806946 DOI: 10.2147/CIA.S225141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
340 Akkouh IA, Ueland T, Hansson L, Inderhaug E, Hughes T, Steen NE, Aukrust P, Andreassen OA, Szabo A, Djurovic S. Decreased IL-1β-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells. Brain Behav Immun 2020;87:634-44. [PMID: 32109548 DOI: 10.1016/j.bbi.2020.02.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
341 Zhao Y, Wang N, Chen J, Guan Q, Yuan X, Shen Y, Zhang X, Hao W, Zhang R, Zhai D. Association between early-onset affective disorders and hypothyroidism in a larger number of psychiatric drug-free patients. J Affect Disord 2021;299:31-6. [PMID: 34838895 DOI: 10.1016/j.jad.2021.11.061] [Reference Citation Analysis]
342 Prata DP, Costa-neves B, Cosme G, Vassos E. Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. Journal of Psychiatric Research 2019;114:178-207. [DOI: 10.1016/j.jpsychires.2019.04.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
343 Chan JKN, Wong CSM, Or PCF, Chen EYH, Chang WC. Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up. Eur Neuropsychopharmacol 2021;53:79-88. [PMID: 34481187 DOI: 10.1016/j.euroneuro.2021.08.263] [Reference Citation Analysis]
344 Chao AM, Wadden TA, Berkowitz RI. Obesity in Adolescents with Psychiatric Disorders. Curr Psychiatry Rep 2019;21:3. [PMID: 30661128 DOI: 10.1007/s11920-019-0990-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]